<pmc-articleset>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4">
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">Nature</journal-id>
        <journal-id journal-id-type="iso-abbrev">Nature</journal-id>
        <journal-id journal-id-type="pmc-domain-id">981</journal-id>
        <journal-id journal-id-type="pmc-domain">npgopen</journal-id>
        <journal-title-group>
          <journal-title>Nature</journal-title>
        </journal-title-group>
        <issn pub-type="ppub">0028-0836</issn>
        <issn pub-type="epub">1476-4687</issn>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-is-collection-domain</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-collection-title</meta-name>
            <meta-value>Nature Portfolio</meta-value>
          </custom-meta>
        </custom-meta-group>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmcid">PMC3401966</article-id>
        <article-id pub-id-type="pmcid-ver">PMC3401966.2</article-id>
        <article-id pub-id-type="pmcaid">3401966</article-id>
        <article-id pub-id-type="pmcaiid">8127819</article-id>
        <article-id pub-id-type="pmid">22810696</article-id>
        <article-id pub-id-type="doi">10.1038/nature11252</article-id>
        <article-id pub-id-type="publisher-id">BFnature11252</article-id>
        <article-version article-version-type="pmc-version">2</article-version>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject>Article</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>Comprehensive molecular characterization of human colon and rectal cancer</article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author">
            <collab>The Cancer Genome Atlas Network<contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Muzny</surname><given-names initials="DM">Donna M.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bainbridge</surname><given-names initials="MN">Matthew N.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chang</surname><given-names initials="K">Kyle</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dinh</surname><given-names initials="HH">Huyen H.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Drummond</surname><given-names initials="JA">Jennifer A.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fowler</surname><given-names initials="G">Gerald</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kovar</surname><given-names initials="CL">Christie L.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lewis</surname><given-names initials="LR">Lora R.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Morgan</surname><given-names initials="MB">Margaret B.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Newsham</surname><given-names initials="IF">Irene F.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Reid</surname><given-names initials="JG">Jeffrey G.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Santibanez</surname><given-names initials="J">Jireh</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shinbrot</surname><given-names initials="E">Eve</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Trevino</surname><given-names initials="LR">Lisa R.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wu</surname><given-names initials="YQ">Yuan-Qing</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="M">Min</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gunaratne</surname><given-names initials="P">Preethi</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Donehower</surname><given-names initials="LA">Lawrence A.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Creighton</surname><given-names initials="CJ">Chad J.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wheeler</surname><given-names initials="DA">David A.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gibbs</surname><given-names initials="RA">Richard A.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><on-behalf-of>for the Genome Sequencing Center Baylor College of Medicine</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Lawrence</surname><given-names initials="MS">Michael S.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Voet</surname><given-names initials="D">Douglas</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jing</surname><given-names initials="R">Rui</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cibulskis</surname><given-names initials="K">Kristian</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sivachenko</surname><given-names initials="A">Andrey</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Stojanov</surname><given-names initials="P">Petar</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>McKenna</surname><given-names initials="A">Aaron</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lander</surname><given-names initials="ES">Eric S.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff7">7</xref><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gabriel</surname><given-names initials="S">Stacey</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Getz</surname><given-names initials="G">Gad</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><on-behalf-of>for the Genome Sequencing Center Broad Institute</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Ding</surname><given-names initials="L">Li</given-names></name><xref ref-type="aff" rid="Aff10">10</xref><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fulton</surname><given-names initials="RS">Robert S.</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Koboldt</surname><given-names initials="DC">Daniel C.</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wylie</surname><given-names initials="T">Todd</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Walker</surname><given-names initials="J">Jason</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dooling</surname><given-names initials="DJ">David J.</given-names></name><xref ref-type="aff" rid="Aff10">10</xref><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fulton</surname><given-names initials="L">Lucinda</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Delehaunty</surname><given-names initials="KD">Kim D.</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fronick</surname><given-names initials="CC">Catrina C.</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Demeter</surname><given-names initials="R">Ryan</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mardis</surname><given-names initials="ER">Elaine R.</given-names></name><xref ref-type="aff" rid="Aff10">10</xref><xref ref-type="aff" rid="Aff11">11</xref><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wilson</surname><given-names initials="RK">Richard K.</given-names></name><xref ref-type="aff" rid="Aff10">10</xref><xref ref-type="aff" rid="Aff11">11</xref><xref ref-type="aff" rid="Aff12">12</xref></contrib><on-behalf-of>for the Genome Sequencing Center Washington University in St Louis</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Chu</surname><given-names initials="A">Andy</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chun</surname><given-names initials="HJE">Hye-Jung E.</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mungall</surname><given-names initials="AJ">Andrew J.</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pleasance</surname><given-names initials="E">Erin</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gordon Robertson</surname><given-names initials="A">A.</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Stoll</surname><given-names initials="D">Dominik</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Balasundaram</surname><given-names initials="M">Miruna</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Birol</surname><given-names initials="I">Inanc</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Butterfield</surname><given-names initials="YSN">Yaron S. N.</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chuah</surname><given-names initials="E">Eric</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Coope</surname><given-names initials="RJN">Robin J. N.</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dhalla</surname><given-names initials="N">Noreen</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Guin</surname><given-names initials="R">Ranabir</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hirst</surname><given-names initials="C">Carrie</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hirst</surname><given-names initials="M">Martin</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Holt</surname><given-names initials="RA">Robert A.</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lee</surname><given-names initials="D">Darlene</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="HI">Haiyan I.</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mayo</surname><given-names initials="M">Michael</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Moore</surname><given-names initials="RA">Richard A.</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Schein</surname><given-names initials="JE">Jacqueline E.</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Slobodan</surname><given-names initials="JR">Jared R.</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tam</surname><given-names initials="A">Angela</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Thiessen</surname><given-names initials="N">Nina</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Varhol</surname><given-names initials="R">Richard</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zeng</surname><given-names initials="T">Thomas</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhao</surname><given-names initials="Y">Yongjun</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jones</surname><given-names initials="SJM">Steven J. M.</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Marra</surname><given-names initials="MA">Marco A.</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><on-behalf-of>for the Genome Characterization Center BC Cancer Agency</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Bass</surname><given-names initials="AJ">Adam J.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ramos</surname><given-names initials="AH">Alex H.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Saksena</surname><given-names initials="G">Gordon</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cherniack</surname><given-names initials="AD">Andrew D.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Schumacher</surname><given-names initials="SE">Stephen E.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tabak</surname><given-names initials="B">Barbara</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Carter</surname><given-names initials="SL">Scott L.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pho</surname><given-names initials="NH">Nam H.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nguyen</surname><given-names initials="H">Huy</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Onofrio</surname><given-names initials="RC">Robert C.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Crenshaw</surname><given-names initials="A">Andrew</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ardlie</surname><given-names initials="K">Kristin</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Beroukhim</surname><given-names initials="R">Rameen</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Winckler</surname><given-names initials="W">Wendy</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Getz</surname><given-names initials="G">Gad</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Meyerson</surname><given-names initials="M">Matthew</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff14">14</xref><xref ref-type="aff" rid="Aff15">15</xref></contrib><on-behalf-of>for the Genome-Characterization Center Broad Institute</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Protopopov</surname><given-names initials="A">Alexei</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="J">Juinhua</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hadjipanayis</surname><given-names initials="A">Angela</given-names></name><xref ref-type="aff" rid="Aff17">17</xref><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lee</surname><given-names initials="E">Eunjung</given-names></name><xref ref-type="aff" rid="Aff18">18</xref><xref ref-type="aff" rid="Aff19">19</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Xi</surname><given-names initials="R">Ruibin</given-names></name><xref ref-type="aff" rid="Aff19">19</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="L">Lixing</given-names></name><xref ref-type="aff" rid="Aff19">19</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ren</surname><given-names initials="X">Xiaojia</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="H">Hailei</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sathiamoorthy</surname><given-names initials="N">Narayanan</given-names></name><xref ref-type="aff" rid="Aff20">20</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shukla</surname><given-names initials="S">Sachet</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="PC">Peng-Chieh</given-names></name><xref ref-type="aff" rid="Aff17">17</xref><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Haseley</surname><given-names initials="P">Psalm</given-names></name><xref ref-type="aff" rid="Aff18">18</xref><xref ref-type="aff" rid="Aff19">19</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Xiao</surname><given-names initials="Y">Yonghong</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lee</surname><given-names initials="S">Semin</given-names></name><xref ref-type="aff" rid="Aff19">19</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Seidman</surname><given-names initials="J">Jonathan</given-names></name><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chin</surname><given-names initials="L">Lynda</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff16">16</xref><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Park</surname><given-names initials="PJ">Peter J.</given-names></name><xref ref-type="aff" rid="Aff18">18</xref><xref ref-type="aff" rid="Aff19">19</xref><xref ref-type="aff" rid="Aff20">20</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Kucherlapati</surname><given-names initials="R">Raju</given-names></name><address><email>rkucherlapati@partners.org</email></address><xref ref-type="aff" rid="Aff17">17</xref><xref ref-type="aff" rid="Aff18">18</xref></contrib><on-behalf-of>for the Genome-Characterization Center Brigham and Women’s Hospital and Harvard Medical School</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Todd Auman</surname><given-names initials="J">J.</given-names></name><xref ref-type="aff" rid="Aff22">22</xref><xref ref-type="aff" rid="Aff23">23</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hoadley</surname><given-names initials="KA">Katherine A.</given-names></name><xref ref-type="aff" rid="Aff24">24</xref><xref ref-type="aff" rid="Aff25">25</xref><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Du</surname><given-names initials="Y">Ying</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wilkerson</surname><given-names initials="MD">Matthew D.</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shi</surname><given-names initials="Y">Yan</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liquori</surname><given-names initials="C">Christina</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Meng</surname><given-names initials="S">Shaowu</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="L">Ling</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Turman</surname><given-names initials="YJ">Yidi J.</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Topal</surname><given-names initials="MD">Michael D.</given-names></name><xref ref-type="aff" rid="Aff25">25</xref><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tan</surname><given-names initials="D">Donghui</given-names></name><xref ref-type="aff" rid="Aff27">27</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Waring</surname><given-names initials="S">Scot</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Buda</surname><given-names initials="E">Elizabeth</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Walsh</surname><given-names initials="J">Jesse</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jones</surname><given-names initials="CD">Corbin D.</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mieczkowski</surname><given-names initials="PA">Piotr A.</given-names></name><xref ref-type="aff" rid="Aff24">24</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Singh</surname><given-names initials="D">Darshan</given-names></name><xref ref-type="aff" rid="Aff29">29</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wu</surname><given-names initials="J">Junyuan</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gulabani</surname><given-names initials="A">Anisha</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dolina</surname><given-names initials="P">Peter</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bodenheimer</surname><given-names initials="T">Tom</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hoyle</surname><given-names initials="AP">Alan P.</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Simons</surname><given-names initials="JV">Janae V.</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Soloway</surname><given-names initials="M">Matthew</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mose</surname><given-names initials="LE">Lisle E.</given-names></name><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jefferys</surname><given-names initials="SR">Stuart R.</given-names></name><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Balu</surname><given-names initials="S">Saianand</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>O’Connor</surname><given-names initials="BD">Brian D.</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Prins</surname><given-names initials="JF">Jan F.</given-names></name><xref ref-type="aff" rid="Aff29">29</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chiang</surname><given-names initials="DY">Derek Y.</given-names></name><xref ref-type="aff" rid="Aff24">24</xref><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Neil Hayes</surname><given-names initials="D">D.</given-names></name><xref ref-type="aff" rid="Aff26">26</xref><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Perou</surname><given-names initials="CM">Charles M.</given-names></name><xref ref-type="aff" rid="Aff24">24</xref><xref ref-type="aff" rid="Aff25">25</xref><xref ref-type="aff" rid="Aff26">26</xref></contrib><on-behalf-of>for the Genome-Characterization Center University of North Carolina, Chapel Hill</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Hinoue</surname><given-names initials="T">Toshinori</given-names></name><xref ref-type="aff" rid="Aff31">31</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Weisenberger</surname><given-names initials="DJ">Daniel J.</given-names></name><xref ref-type="aff" rid="Aff31">31</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Maglinte</surname><given-names initials="DT">Dennis T.</given-names></name><xref ref-type="aff" rid="Aff31">31</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pan</surname><given-names initials="F">Fei</given-names></name><xref ref-type="aff" rid="Aff31">31</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Berman</surname><given-names initials="BP">Benjamin P.</given-names></name><xref ref-type="aff" rid="Aff31">31</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Van Den Berg</surname><given-names initials="DJ">David J.</given-names></name><xref ref-type="aff" rid="Aff31">31</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shen</surname><given-names initials="H">Hui</given-names></name><xref ref-type="aff" rid="Aff31">31</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Triche Jr</surname><given-names initials="T">Timothy</given-names></name><xref ref-type="aff" rid="Aff31">31</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Baylin</surname><given-names initials="SB">Stephen B.</given-names></name><xref ref-type="aff" rid="Aff32">32</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Laird</surname><given-names initials="PW">Peter W.</given-names></name><xref ref-type="aff" rid="Aff31">31</xref></contrib><on-behalf-of>for the Genome-Characterization Centers University of Southern California and Johns Hopkins University</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Getz</surname><given-names initials="G">Gad</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Noble</surname><given-names initials="M">Michael</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Voet</surname><given-names initials="D">Doug</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Saksena</surname><given-names initials="G">Gordon</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gehlenborg</surname><given-names initials="N">Nils</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff19">19</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>DiCara</surname><given-names initials="D">Daniel</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="J">Juinhua</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="H">Hailei</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wu</surname><given-names initials="CJ">Chang-Jiun</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yingchun Liu</surname><given-names initials="S">Spring</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shukla</surname><given-names initials="S">Sachet</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lawrence</surname><given-names initials="MS">Michael S.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhou</surname><given-names initials="L">Lihua</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sivachenko</surname><given-names initials="A">Andrey</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lin</surname><given-names initials="P">Pei</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Stojanov</surname><given-names initials="P">Petar</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jing</surname><given-names initials="R">Rui</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Park</surname><given-names initials="RW">Richard W.</given-names></name><xref ref-type="aff" rid="Aff19">19</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nazaire</surname><given-names initials="MD">Marc-Danie</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Robinson</surname><given-names initials="J">Jim</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Thorvaldsdottir</surname><given-names initials="H">Helga</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mesirov</surname><given-names initials="J">Jill</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Park</surname><given-names initials="PJ">Peter J.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chin</surname><given-names initials="L">Lynda</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff16">16</xref><xref ref-type="aff" rid="Aff21">21</xref></contrib><on-behalf-of>for the Genome Data Analysis Center Broad Institute</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Thorsson</surname><given-names initials="V">Vesteinn</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Reynolds</surname><given-names initials="SM">Sheila M.</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bernard</surname><given-names initials="B">Brady</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kreisberg</surname><given-names initials="R">Richard</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lin</surname><given-names initials="J">Jake</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Iype</surname><given-names initials="L">Lisa</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bressler</surname><given-names initials="R">Ryan</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Erkkilä</surname><given-names initials="T">Timo</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gundapuneni</surname><given-names initials="M">Madhumati</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="Y">Yuexin</given-names></name><xref ref-type="aff" rid="Aff34">34</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Norberg</surname><given-names initials="A">Adam</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Robinson</surname><given-names initials="T">Tom</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="D">Da</given-names></name><xref ref-type="aff" rid="Aff34">34</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="W">Wei</given-names></name><xref ref-type="aff" rid="Aff34">34</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shmulevich</surname><given-names initials="I">Ilya</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><on-behalf-of>for the Genome Data Analysis Center Institute for Systems Biology</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>de Ronde</surname><given-names initials="JJ">Jorma J.</given-names></name><xref ref-type="aff" rid="Aff35">35</xref><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Schultz</surname><given-names initials="N">Nikolaus</given-names></name><xref ref-type="aff" rid="Aff35">35</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cerami</surname><given-names initials="E">Ethan</given-names></name><xref ref-type="aff" rid="Aff35">35</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ciriello</surname><given-names initials="G">Giovanni</given-names></name><xref ref-type="aff" rid="Aff35">35</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Goldberg</surname><given-names initials="AP">Arthur P.</given-names></name><xref ref-type="aff" rid="Aff35">35</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gross</surname><given-names initials="B">Benjamin</given-names></name><xref ref-type="aff" rid="Aff35">35</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jacobsen</surname><given-names initials="A">Anders</given-names></name><xref ref-type="aff" rid="Aff35">35</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gao</surname><given-names initials="J">Jianjiong</given-names></name><xref ref-type="aff" rid="Aff35">35</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kaczkowski</surname><given-names initials="B">Bogumil</given-names></name><xref ref-type="aff" rid="Aff35">35</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sinha</surname><given-names initials="R">Rileen</given-names></name><xref ref-type="aff" rid="Aff35">35</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Arman Aksoy</surname><given-names initials="B">B.</given-names></name><xref ref-type="aff" rid="Aff35">35</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Antipin</surname><given-names initials="Y">Yevgeniy</given-names></name><xref ref-type="aff" rid="Aff35">35</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Reva</surname><given-names initials="B">Boris</given-names></name><xref ref-type="aff" rid="Aff35">35</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shen</surname><given-names initials="R">Ronglai</given-names></name><xref ref-type="aff" rid="Aff37">37</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Taylor</surname><given-names initials="BS">Barry S.</given-names></name><xref ref-type="aff" rid="Aff35">35</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chan</surname><given-names initials="TA">Timothy A.</given-names></name><xref ref-type="aff" rid="Aff38">38</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ladanyi</surname><given-names initials="M">Marc</given-names></name><xref ref-type="aff" rid="Aff39">39</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sander</surname><given-names initials="C">Chris</given-names></name><xref ref-type="aff" rid="Aff35">35</xref></contrib><on-behalf-of>for the Genome Data Analysis Center Memorial Sloan-Kettering Cancer Center</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Akbani</surname><given-names initials="R">Rehan</given-names></name><xref ref-type="aff" rid="Aff40">40</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="N">Nianxiang</given-names></name><xref ref-type="aff" rid="Aff40">40</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Broom</surname><given-names initials="BM">Bradley M.</given-names></name><xref ref-type="aff" rid="Aff40">40</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Casasent</surname><given-names initials="T">Tod</given-names></name><xref ref-type="aff" rid="Aff40">40</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Unruh</surname><given-names initials="A">Anna</given-names></name><xref ref-type="aff" rid="Aff40">40</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wakefield</surname><given-names initials="C">Chris</given-names></name><xref ref-type="aff" rid="Aff40">40</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hamilton</surname><given-names initials="SR">Stanley R.</given-names></name><xref ref-type="aff" rid="Aff34">34</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Craig Cason</surname><given-names initials="R">R.</given-names></name><xref ref-type="aff" rid="Aff34">34</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Baggerly</surname><given-names initials="KA">Keith A.</given-names></name><xref ref-type="aff" rid="Aff40">40</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Weinstein</surname><given-names initials="JN">John N.</given-names></name><xref ref-type="aff" rid="Aff40">40</xref><xref ref-type="aff" rid="Aff41">41</xref></contrib><on-behalf-of>for the Genome Data Analysis Center University of Texas MD Anderson Cancer Center</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Haussler</surname><given-names initials="D">David</given-names></name><xref ref-type="aff" rid="Aff42">42</xref><xref ref-type="aff" rid="Aff43">43</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Benz</surname><given-names initials="CC">Christopher C.</given-names></name><xref ref-type="aff" rid="Aff44">44</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Stuart</surname><given-names initials="JM">Joshua M.</given-names></name><xref ref-type="aff" rid="Aff42">42</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Benz</surname><given-names initials="SC">Stephen C.</given-names></name><xref ref-type="aff" rid="Aff42">42</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zachary Sanborn</surname><given-names initials="J">J.</given-names></name><xref ref-type="aff" rid="Aff42">42</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Vaske</surname><given-names initials="CJ">Charles J.</given-names></name><xref ref-type="aff" rid="Aff42">42</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhu</surname><given-names initials="J">Jingchun</given-names></name><xref ref-type="aff" rid="Aff42">42</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Szeto</surname><given-names initials="C">Christopher</given-names></name><xref ref-type="aff" rid="Aff42">42</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Scott</surname><given-names initials="GK">Gary K.</given-names></name><xref ref-type="aff" rid="Aff44">44</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yau</surname><given-names initials="C">Christina</given-names></name><xref ref-type="aff" rid="Aff44">44</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ng</surname><given-names initials="S">Sam</given-names></name><xref ref-type="aff" rid="Aff42">42</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Goldstein</surname><given-names initials="T">Ted</given-names></name><xref ref-type="aff" rid="Aff42">42</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ellrott</surname><given-names initials="K">Kyle</given-names></name><xref ref-type="aff" rid="Aff42">42</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Collisson</surname><given-names initials="E">Eric</given-names></name><xref ref-type="aff" rid="Aff45">45</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cozen</surname><given-names initials="AE">Aaron E.</given-names></name><xref ref-type="aff" rid="Aff42">42</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zerbino</surname><given-names initials="D">Daniel</given-names></name><xref ref-type="aff" rid="Aff42">42</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wilks</surname><given-names initials="C">Christopher</given-names></name><xref ref-type="aff" rid="Aff42">42</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Craft</surname><given-names initials="B">Brian</given-names></name><xref ref-type="aff" rid="Aff42">42</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Spellman</surname><given-names initials="P">Paul</given-names></name><xref ref-type="aff" rid="Aff46">46</xref></contrib><on-behalf-of>for the Genome Data Analysis Centers, University of California, Santa Cruz and the Buck Institute</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Penny</surname><given-names initials="R">Robert</given-names></name><xref ref-type="aff" rid="Aff47">47</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shelton</surname><given-names initials="T">Troy</given-names></name><xref ref-type="aff" rid="Aff47">47</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hatfield</surname><given-names initials="M">Martha</given-names></name><xref ref-type="aff" rid="Aff47">47</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Morris</surname><given-names initials="S">Scott</given-names></name><xref ref-type="aff" rid="Aff47">47</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yena</surname><given-names initials="P">Peggy</given-names></name><xref ref-type="aff" rid="Aff47">47</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shelton</surname><given-names initials="C">Candace</given-names></name><xref ref-type="aff" rid="Aff47">47</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sherman</surname><given-names initials="M">Mark</given-names></name><xref ref-type="aff" rid="Aff47">47</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Paulauskis</surname><given-names initials="J">Joseph</given-names></name><xref ref-type="aff" rid="Aff47">47</xref></contrib><on-behalf-of>for the Biospecimen Core Resource International Genomics Consortium</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Gastier-Foster</surname><given-names initials="JM">Julie M.</given-names></name><xref ref-type="aff" rid="Aff48">48</xref><xref ref-type="aff" rid="Aff49">49</xref><xref ref-type="aff" rid="Aff50">50</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bowen</surname><given-names initials="J">Jay</given-names></name><xref ref-type="aff" rid="Aff48">48</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ramirez</surname><given-names initials="NC">Nilsa C.</given-names></name><xref ref-type="aff" rid="Aff48">48</xref><xref ref-type="aff" rid="Aff49">49</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Black</surname><given-names initials="A">Aaron</given-names></name><xref ref-type="aff" rid="Aff48">48</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pyatt</surname><given-names initials="R">Robert</given-names></name><xref ref-type="aff" rid="Aff48">48</xref><xref ref-type="aff" rid="Aff49">49</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wise</surname><given-names initials="L">Lisa</given-names></name><xref ref-type="aff" rid="Aff48">48</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>White</surname><given-names initials="P">Peter</given-names></name><xref ref-type="aff" rid="Aff48">48</xref><xref ref-type="aff" rid="Aff50">50</xref></contrib><on-behalf-of>for the Nationwide Children’s Hospital Biospecimen Core Resource</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Bertagnolli</surname><given-names initials="M">Monica</given-names></name><xref ref-type="aff" rid="Aff51">51</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Brown</surname><given-names initials="J">Jen</given-names></name><xref ref-type="aff" rid="Aff52">52</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chan</surname><given-names initials="TA">Timothy A.</given-names></name><xref ref-type="aff" rid="Aff53">53</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chu</surname><given-names initials="GC">Gerald C.</given-names></name><xref ref-type="aff" rid="Aff54">54</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Czerwinski</surname><given-names initials="C">Christine</given-names></name><xref ref-type="aff" rid="Aff52">52</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Denstman</surname><given-names initials="F">Fred</given-names></name><xref ref-type="aff" rid="Aff55">55</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dhir</surname><given-names initials="R">Rajiv</given-names></name><xref ref-type="aff" rid="Aff56">56</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dörner</surname><given-names initials="A">Arnulf</given-names></name><xref ref-type="aff" rid="Aff57">57</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fuchs</surname><given-names initials="CS">Charles S.</given-names></name><xref ref-type="aff" rid="Aff58">58</xref><xref ref-type="aff" rid="Aff59">59</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Guillem</surname><given-names initials="JG">Jose G.</given-names></name><xref ref-type="aff" rid="Aff60">60</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Iacocca</surname><given-names initials="M">Mary</given-names></name><xref ref-type="aff" rid="Aff52">52</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Juhl</surname><given-names initials="H">Hartmut</given-names></name><xref ref-type="aff" rid="Aff61">61</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kaufman</surname><given-names initials="A">Andrew</given-names></name><xref ref-type="aff" rid="Aff53">53</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kohl III</surname><given-names initials="B">Bernard</given-names></name><xref ref-type="aff" rid="Aff62">62</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Van Le</surname><given-names initials="X">Xuan</given-names></name><xref ref-type="aff" rid="Aff62">62</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mariano</surname><given-names initials="MC">Maria C.</given-names></name><xref ref-type="aff" rid="Aff63">63</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Medina</surname><given-names initials="EN">Elizabeth N.</given-names></name><xref ref-type="aff" rid="Aff63">63</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Meyers</surname><given-names initials="M">Michael</given-names></name><xref ref-type="aff" rid="Aff64">64</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nash</surname><given-names initials="GM">Garrett M.</given-names></name><xref ref-type="aff" rid="Aff60">60</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Paty</surname><given-names initials="PB">Phillip B.</given-names></name><xref ref-type="aff" rid="Aff60">60</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Petrelli</surname><given-names initials="N">Nicholas</given-names></name><xref ref-type="aff" rid="Aff55">55</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rabeno</surname><given-names initials="B">Brenda</given-names></name><xref ref-type="aff" rid="Aff52">52</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Richards</surname><given-names initials="WG">William G.</given-names></name><xref ref-type="aff" rid="Aff65">65</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Solit</surname><given-names initials="D">David</given-names></name><xref ref-type="aff" rid="Aff67">67</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Swanson</surname><given-names initials="P">Pat</given-names></name><xref ref-type="aff" rid="Aff52">52</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Temple</surname><given-names initials="L">Larissa</given-names></name><xref ref-type="aff" rid="Aff53">53</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tepper</surname><given-names initials="JE">Joel E.</given-names></name><xref ref-type="aff" rid="Aff66">66</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Thorp</surname><given-names initials="R">Richard</given-names></name><xref ref-type="aff" rid="Aff62">62</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Vakiani</surname><given-names initials="E">Efsevia</given-names></name><xref ref-type="aff" rid="Aff63">63</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Weiser</surname><given-names initials="MR">Martin R.</given-names></name><xref ref-type="aff" rid="Aff60">60</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Willis</surname><given-names initials="JE">Joseph E.</given-names></name><xref ref-type="aff" rid="Aff68">68</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Witkin</surname><given-names initials="G">Gary</given-names></name><xref ref-type="aff" rid="Aff52">52</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zeng</surname><given-names initials="Z">Zhaoshi</given-names></name><xref ref-type="aff" rid="Aff60">60</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zinner</surname><given-names initials="MJ">Michael J.</given-names></name><xref ref-type="aff" rid="Aff64">64</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zornig</surname><given-names initials="C">Carsten</given-names></name><xref ref-type="aff" rid="Aff69">69</xref></contrib><on-behalf-of>for the Tissue source sites and disease working group</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Jensen</surname><given-names initials="MA">Mark A.</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sfeir</surname><given-names initials="R">Robert</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kahn</surname><given-names initials="AB">Ari B.</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chu</surname><given-names initials="AL">Anna L.</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kothiyal</surname><given-names initials="P">Prachi</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="Z">Zhining</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Snyder</surname><given-names initials="EE">Eric E.</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pontius</surname><given-names initials="J">Joan</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pihl</surname><given-names initials="TD">Todd D.</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ayala</surname><given-names initials="B">Brenda</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Backus</surname><given-names initials="M">Mark</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Walton</surname><given-names initials="J">Jessica</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Whitmore</surname><given-names initials="J">Jon</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Baboud</surname><given-names initials="J">Julien</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Berton</surname><given-names initials="DL">Dominique L.</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nicholls</surname><given-names initials="MC">Matthew C.</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Srinivasan</surname><given-names initials="D">Deepak</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Raman</surname><given-names initials="R">Rohini</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Girshik</surname><given-names initials="S">Stanley</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kigonya</surname><given-names initials="PA">Peter A.</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Alonso</surname><given-names initials="S">Shelley</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sanbhadti</surname><given-names initials="RN">Rashmi N.</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Barletta</surname><given-names initials="SP">Sean P.</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Greene</surname><given-names initials="JM">John M.</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pot</surname><given-names initials="DA">David A.</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><on-behalf-of>for the Data-Coordination Center</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Mills Shaw</surname><given-names initials="KR">Kenna R.</given-names></name><xref ref-type="aff" rid="Aff71">71</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dillon</surname><given-names initials="LAL">Laura A. L.</given-names></name><xref ref-type="aff" rid="Aff71">71</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Buetow</surname><given-names initials="K">Ken</given-names></name><xref ref-type="aff" rid="Aff72">72</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Davidsen</surname><given-names initials="T">Tanja</given-names></name><xref ref-type="aff" rid="Aff72">72</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Demchok</surname><given-names initials="JA">John A.</given-names></name><xref ref-type="aff" rid="Aff71">71</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Eley</surname><given-names initials="G">Greg</given-names></name><xref ref-type="aff" rid="Aff73">73</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ferguson</surname><given-names initials="M">Martin</given-names></name><xref ref-type="aff" rid="Aff74">74</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fielding</surname><given-names initials="P">Peter</given-names></name><xref ref-type="aff" rid="Aff71">71</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Schaefer</surname><given-names initials="C">Carl</given-names></name><xref ref-type="aff" rid="Aff72">72</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sheth</surname><given-names initials="M">Margi</given-names></name><xref ref-type="aff" rid="Aff71">71</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="L">Liming</given-names></name><xref ref-type="aff" rid="Aff71">71</xref></contrib><on-behalf-of>for the Project Team National Cancer Institute</on-behalf-of></contrib-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Guyer</surname><given-names initials="MS">Mark S.</given-names></name><xref ref-type="aff" rid="Aff75">75</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ozenberger</surname><given-names initials="BA">Bradley A.</given-names></name><xref ref-type="aff" rid="Aff75">75</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Palchik</surname><given-names initials="JD">Jacqueline D.</given-names></name><xref ref-type="aff" rid="Aff75">75</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Peterson</surname><given-names initials="J">Jane</given-names></name><xref ref-type="aff" rid="Aff75">75</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sofia</surname><given-names initials="HJ">Heidi J.</given-names></name><xref ref-type="aff" rid="Aff75">75</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Thomson.</surname><given-names initials="E">Elizabeth</given-names></name><xref ref-type="aff" rid="Aff75">75</xref></contrib><on-behalf-of>for the Project Team National Human Genome Research Institute</on-behalf-of></contrib-group></collab>
          </contrib>
          <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.39382.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2160 926X</institution-id><institution>Human Genome Sequencing Center, Baylor College of Medicine, </institution></institution-wrap>Houston, 77030 Texas USA </aff>
          <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.266436.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 1569 9707</institution-id><institution>Department of Biology and Biochemistry, </institution><institution>University of Houston, </institution></institution-wrap>Houston, 77204 Texas USA </aff>
          <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.39382.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2160 926X</institution-id><institution>Dan L. Duncan Cancer Center, Human Genome Sequencing Center, Baylor College of Medicine, </institution></institution-wrap>Houston, 77030 Texas USA </aff>
          <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.66859.34</institution-id><institution>The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, </institution></institution-wrap>Cambridge, 02142 Massachusetts USA </aff>
          <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Medical Sequencing Analysis and Informatics, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, </institution></institution-wrap>Cambridge, 02142 Massachusetts USA </aff>
          <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.116068.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 2341 2786</institution-id><institution>Department of Biology, </institution><institution>Massachusetts Institute of Technology, </institution></institution-wrap>Cambridge, 02142 Massachusetts USA </aff>
          <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Department of Systems Biology, </institution><institution>Harvard University, </institution></institution-wrap>Boston, 02115 Massachusetts USA </aff>
          <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Genetic Analysis Platform, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, </institution></institution-wrap>Cambridge, 02142 Massachusetts USA </aff>
          <aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.4367.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2355 7002</institution-id><institution>The Genome Institute, Washington University School of Medicine, St Louis, Missouri 63108 USA., </institution></institution-wrap>, </aff>
          <aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="GRID">grid.4367.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2355 7002</institution-id><institution>Department of Genetics, </institution><institution>Washington University School of Medicine, </institution></institution-wrap>St Louis, 63108 Missouri USA </aff>
          <aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="GRID">grid.4367.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2355 7002</institution-id><institution>Siteman Cancer Center, Washington University School of Medicine, </institution></institution-wrap>St Louis, 63108 Missouri USA </aff>
          <aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="GRID">grid.248762.d</institution-id><institution-id institution-id-type="ISNI">0000 0001 0702 3000</institution-id><institution>Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency, </institution></institution-wrap>Vancouver, V5Z 1L3 British Columbia Canada </aff>
          <aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="GRID">grid.65499.37</institution-id><institution-id institution-id-type="ISNI">0000 0001 2106 9910</institution-id><institution>Department of Medical Oncology, </institution><institution>Dana-Farber Cancer Institute, </institution></institution-wrap>Boston, 02115 Massachusetts USA </aff>
          <aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Department of Pathology, </institution><institution>Harvard Medical School, </institution></institution-wrap>Boston, 02115 Massachusetts USA </aff>
          <aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="GRID">grid.65499.37</institution-id><institution-id institution-id-type="ISNI">0000 0001 2106 9910</institution-id><institution>Department of Medical Oncology, </institution><institution>Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, </institution></institution-wrap>Boston, 02115 Massachusetts USA </aff>
          <aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Department of Genetics, </institution><institution>Harvard Medical School, </institution></institution-wrap>Boston, 02115 Massachusetts USA </aff>
          <aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="GRID">grid.62560.37</institution-id><institution-id institution-id-type="ISNI">0000 0004 0378 8294</institution-id><institution>Division of Genetics, </institution><institution>Brigham and Women’s Hospital, Boston, Massachusetts 02115, USA., </institution></institution-wrap>, </aff>
          <aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>The Center for Biomedical Informatics, Harvard Medical School, </institution></institution-wrap>Boston, 02115 Massachusetts USA </aff>
          <aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="GRID">grid.2515.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0378 8438</institution-id><institution>Informatics Program, Children’s Hospital, </institution></institution-wrap>Boston, 02115 Massachusetts USA </aff>
          <aff id="Aff21"><label>21</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Department of Dermatology, </institution><institution>Harvard Medical School, </institution></institution-wrap>Boston, 02115 Massachusetts USA </aff>
          <aff id="Aff22"><label>22</label><institution-wrap><institution-id institution-id-type="GRID">grid.10698.36</institution-id><institution-id institution-id-type="ISNI">0000000122483208</institution-id><institution>Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, </institution></institution-wrap>Chapel Hill, 27599 North Carolina USA </aff>
          <aff id="Aff23"><label>23</label><institution-wrap><institution-id institution-id-type="GRID">grid.10698.36</institution-id><institution-id institution-id-type="ISNI">0000000122483208</institution-id><institution>Institute for Pharmacogenetics and Individualized Therapy, University of North Carolina at Chapel Hill, </institution></institution-wrap>Chapel Hill, 27599 North Carolina USA </aff>
          <aff id="Aff24"><label>24</label><institution-wrap><institution-id institution-id-type="GRID">grid.10698.36</institution-id><institution-id institution-id-type="ISNI">0000000122483208</institution-id><institution>Department of Genetics, </institution><institution>University of North Carolina at Chapel Hill, </institution></institution-wrap>Chapel Hill, 27599 North Carolina USA </aff>
          <aff id="Aff25"><label>25</label><institution-wrap><institution-id institution-id-type="GRID">grid.10698.36</institution-id><institution-id institution-id-type="ISNI">0000000122483208</institution-id><institution>Department of Pathology and Laboratory Medicine, </institution><institution>University of North Carolina at Chapel Hill, </institution></institution-wrap>Chapel Hill, 27599 North Carolina USA </aff>
          <aff id="Aff26"><label>26</label><institution-wrap><institution-id institution-id-type="GRID">grid.10698.36</institution-id><institution-id institution-id-type="ISNI">0000000122483208</institution-id><institution>Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, </institution></institution-wrap>Chapel Hill, 27599 North Carolina USA </aff>
          <aff id="Aff27"><label>27</label><institution-wrap><institution-id institution-id-type="GRID">grid.10698.36</institution-id><institution-id institution-id-type="ISNI">0000000122483208</institution-id><institution>Carolina Center for Genome Sciences, University of North Carolina at Chapel Hill, </institution></institution-wrap>Chapel Hill, 27599 North Carolina USA </aff>
          <aff id="Aff28"><label>28</label><institution-wrap><institution-id institution-id-type="GRID">grid.10698.36</institution-id><institution-id institution-id-type="ISNI">0000000122483208</institution-id><institution>Department of Biology, </institution><institution>University of North Carolina at Chapel Hill, </institution></institution-wrap>Chapel Hill, 27599 North Carolina USA </aff>
          <aff id="Aff29"><label>29</label><institution-wrap><institution-id institution-id-type="GRID">grid.10698.36</institution-id><institution-id institution-id-type="ISNI">0000000122483208</institution-id><institution>Department of Computer Science, </institution><institution>University of North Carolina at Chapel Hill, </institution></institution-wrap>Chapel Hill, 27599 North Carolina USA </aff>
          <aff id="Aff30"><label>30</label><institution-wrap><institution-id institution-id-type="GRID">grid.10698.36</institution-id><institution-id institution-id-type="ISNI">0000000122483208</institution-id><institution>Department of Internal Medicine, Division of Medical Oncology, </institution><institution>University of North Carolina at Chapel Hill, </institution></institution-wrap>Chapel Hill, 27599 North Carolina USA </aff>
          <aff id="Aff31"><label>31</label><institution-wrap><institution-id institution-id-type="GRID">grid.42505.36</institution-id><institution-id institution-id-type="ISNI">0000 0001 2156 6853</institution-id><institution>University of Southern California Epigenome Center, University of Southern California, </institution></institution-wrap>Los Angeles, 90089 California USA </aff>
          <aff id="Aff32"><label>32</label><institution-wrap><institution-id institution-id-type="GRID">grid.469474.c</institution-id><institution-id institution-id-type="ISNI">0000 0000 8617 4175</institution-id><institution>Cancer Biology Division, </institution><institution>The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, </institution></institution-wrap>Baltimore, 21231 Maryland USA </aff>
          <aff id="Aff33"><label>33</label><institution-wrap><institution-id institution-id-type="GRID">grid.64212.33</institution-id><institution-id institution-id-type="ISNI">0000 0004 0463 2320</institution-id><institution>Institute for Systems Biology, </institution></institution-wrap>Seattle, 98109 Washington USA </aff>
          <aff id="Aff34"><label>34</label><institution-wrap><institution-id institution-id-type="GRID">grid.240145.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2291 4776</institution-id><institution>Division of Pathology and Laboratory Medicine, </institution><institution>The University of Texas MD Anderson Cancer Center, </institution></institution-wrap>Houston, 77030 Texas USA </aff>
          <aff id="Aff35"><label>35</label><institution-wrap><institution-id institution-id-type="GRID">grid.51462.34</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9952</institution-id><institution>Computational Biology Center, Memorial Sloan-Kettering Cancer Center, </institution></institution-wrap>New York, 10065 New York USA </aff>
          <aff id="Aff36"><label>36</label><institution-wrap><institution-id institution-id-type="GRID">grid.430814.a</institution-id><institution>Divisions of Experimental Therapy, </institution><institution>Molecular Biology, Surgical Oncology, The Netherlands Cancer Institute, </institution></institution-wrap>1066 CX Amsterdam, The Netherlands </aff>
          <aff id="Aff37"><label>37</label><institution-wrap><institution-id institution-id-type="GRID">grid.51462.34</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9952</institution-id><institution>Department of Epidemiology and Biostatistics, </institution><institution>Memorial Sloan-Kettering Cancer Center, </institution></institution-wrap>New York, 10065 New York USA </aff>
          <aff id="Aff38"><label>38</label><institution-wrap><institution-id institution-id-type="GRID">grid.51462.34</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9952</institution-id><institution>Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, </institution></institution-wrap>New York, 10065 New York USA </aff>
          <aff id="Aff39"><label>39</label><institution-wrap><institution-id institution-id-type="GRID">grid.51462.34</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9952</institution-id><institution>Department of Pathology, </institution><institution>Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, </institution></institution-wrap>New York, 10065 New York USA </aff>
          <aff id="Aff40"><label>40</label><institution-wrap><institution-id institution-id-type="GRID">grid.240145.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2291 4776</institution-id><institution>Department of Bioinformatics and Computational Biology, </institution><institution>The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA., </institution></institution-wrap>, </aff>
          <aff id="Aff41"><label>41</label><institution-wrap><institution-id institution-id-type="GRID">grid.240145.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2291 4776</institution-id><institution>Department of Systems Biology, </institution><institution>The University of Texas MD Anderson Cancer Center, </institution></institution-wrap>Houston, 77030 Texas USA </aff>
          <aff id="Aff42"><label>42</label><institution-wrap><institution-id institution-id-type="GRID">grid.205975.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0740 6917</institution-id><institution>Department of Biomolecular Engineering and Center for Biomolecular Science and Engineering, </institution><institution>University of California Santa Cruz, </institution></institution-wrap>Santa Cruz, 95064 California USA </aff>
          <aff id="Aff43"><label>43</label><institution-wrap><institution-id institution-id-type="GRID">grid.205975.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0740 6917</institution-id><institution>Howard Hughes Medical Institute, University of California Santa Cruz, </institution></institution-wrap>Santa Cruz, 95064 California USA </aff>
          <aff id="Aff44"><label>44</label><institution-wrap><institution-id institution-id-type="GRID">grid.272799.0</institution-id><institution-id institution-id-type="ISNI">0000 0000 8687 5377</institution-id><institution>Buck Institute for Age Research, </institution></institution-wrap>Novato, 94945 California USA </aff>
          <aff id="Aff45"><label>45</label><institution-wrap><institution-id institution-id-type="GRID">grid.266102.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2297 6811</institution-id><institution>Division of Hematology/Oncology, </institution><institution>University of California San Francisco, </institution></institution-wrap>San Francisco, 94143 California USA </aff>
          <aff id="Aff46"><label>46</label><institution-wrap><institution-id institution-id-type="GRID">grid.5288.7</institution-id><institution-id institution-id-type="ISNI">0000 0000 9758 5690</institution-id><institution>Department of Molecular and Medical Genetics, </institution><institution>Oregon Health and Science University, </institution></institution-wrap>Portland, 97239 Oregon USA </aff>
          <aff id="Aff47"><label>47</label><institution-wrap><institution-id institution-id-type="GRID">grid.450294.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 0641 0756</institution-id><institution>International Genomics Consortium, </institution></institution-wrap>Phoenix, 85004 Arizona USA </aff>
          <aff id="Aff48"><label>48</label><institution-wrap><institution-id institution-id-type="GRID">grid.240344.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0392 3476</institution-id><institution>Nationwide Children’s Hospital Biospecimen Core Resource, The Research Institute at Nationwide Children’s Hospital, Columbus, Ohio 43205, USA., </institution></institution-wrap>, </aff>
          <aff id="Aff49"><label>49</label><institution-wrap><institution-id institution-id-type="GRID">grid.261331.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 2285 7943</institution-id><institution>Department of Pathology, </institution><institution>The Ohio State University College of Medicine, </institution></institution-wrap>Columbus, 43205 Ohio USA </aff>
          <aff id="Aff50"><label>50</label><institution-wrap><institution-id institution-id-type="GRID">grid.261331.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 2285 7943</institution-id><institution>Department of Pediatrics, </institution><institution>The Ohio State University College of Medicine, </institution></institution-wrap>Columbus, 43205 Ohio USA </aff>
          <aff id="Aff51"><label>51</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Department of Surgery, </institution><institution>Brigham and Women’s Hospital, Harvard Medical School, </institution></institution-wrap>Brookline, 02115 Massachusetts USA </aff>
          <aff id="Aff52"><label>52</label><institution-wrap><institution-id institution-id-type="GRID">grid.414316.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0444 1241</institution-id><institution>Department of Pathology, </institution><institution>Christiana Care Health Services, Newark, Delaware 19718, USA., </institution></institution-wrap>, </aff>
          <aff id="Aff53"><label>53</label><institution-wrap><institution-id institution-id-type="GRID">grid.51462.34</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9952</institution-id><institution>Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, </institution></institution-wrap>New York, 10065 New York USA </aff>
          <aff id="Aff54"><label>54</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Department of Pathology, </institution><institution>Brigham and Women’s Hospital, Harvard Medical School, </institution></institution-wrap>Brookline, 02115 Massachusetts USA </aff>
          <aff id="Aff55"><label>55</label><institution-wrap><institution-id institution-id-type="GRID">grid.414316.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0444 1241</institution-id><institution>Department of Surgery, </institution><institution>Helen F. Graham Cancer Center at Christiana Care, </institution></institution-wrap>Newark, 19718 Delaware USA </aff>
          <aff id="Aff56"><label>56</label><institution-wrap><institution-id institution-id-type="GRID">grid.21925.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9000</institution-id><institution>Department of Pathology, </institution><institution>University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA., </institution></institution-wrap>, </aff>
          <aff id="Aff57"><label>57</label>Klinik für Chirurgie, Krankenhaus Alten Eichen, Hamburg, 22527 Germany </aff>
          <aff id="Aff58"><label>58</label><institution-wrap><institution-id institution-id-type="GRID">grid.65499.37</institution-id><institution-id institution-id-type="ISNI">0000 0001 2106 9910</institution-id><institution>Department of Medical Oncology, </institution><institution>Dana-Farber Cancer Institute, </institution></institution-wrap>Brookline, 02115 Massachusetts USA </aff>
          <aff id="Aff59"><label>59</label><institution-wrap><institution-id institution-id-type="GRID">grid.62560.37</institution-id><institution-id institution-id-type="ISNI">0000 0004 0378 8294</institution-id><institution>Department of Medicine, </institution><institution>Brigham and Women’s Hospital, </institution></institution-wrap>Brookline, 02115 Massachusetts USA </aff>
          <aff id="Aff60"><label>60</label><institution-wrap><institution-id institution-id-type="GRID">grid.51462.34</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9952</institution-id><institution>Department of Surgery, </institution><institution>Memorial Sloan-Kettering Cancer Center, </institution></institution-wrap>New York, 10065 New York USA </aff>
          <aff id="Aff61"><label>61</label>Indivumed Inc., Kensington, 20895 Maryland USA </aff>
          <aff id="Aff62"><label>62</label>ILSbio, LLC, Chestertown, 21620 Maryland USA </aff>
          <aff id="Aff63"><label>63</label><institution-wrap><institution-id institution-id-type="GRID">grid.51462.34</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9952</institution-id><institution>Department of Pathology, </institution><institution>Memorial Sloan-Kettering Cancer Center, </institution></institution-wrap>New York, 10065 New York USA </aff>
          <aff id="Aff64"><label>64</label><institution-wrap><institution-id institution-id-type="GRID">grid.62560.37</institution-id><institution-id institution-id-type="ISNI">0000 0004 0378 8294</institution-id><institution>Department of Surgery, </institution><institution>Brigham and Women’s Hospital, Brookline, </institution></institution-wrap>02115 Massachusetts USA </aff>
          <aff id="Aff65"><label>65</label><institution-wrap><institution-id institution-id-type="GRID">grid.62560.37</institution-id><institution-id institution-id-type="ISNI">0000 0004 0378 8294</institution-id><institution>Tissue and Blood Repository, Brigham and Women’s Hospital, Brookline, </institution></institution-wrap>02115 Massachusetts USA </aff>
          <aff id="Aff66"><label>66</label><institution-wrap><institution-id institution-id-type="GRID">grid.10698.36</institution-id><institution-id institution-id-type="ISNI">0000000122483208</institution-id><institution>Dept of Radiation Oncology, University of North Carolina School of Medicine, </institution></institution-wrap>Chapel Hill, 27599 North Carolina USA </aff>
          <aff id="Aff67"><label>67</label><institution-wrap><institution-id institution-id-type="GRID">grid.51462.34</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9952</institution-id><institution>Department of Medicine, </institution><institution>Memorial Sloan-Kettering Cancer Center, </institution></institution-wrap>New York, 10065 New York USA </aff>
          <aff id="Aff68"><label>68</label><institution-wrap><institution-id institution-id-type="GRID">grid.443867.a</institution-id><institution-id institution-id-type="ISNI">0000 0000 9149 4843</institution-id><institution>Department of Pathology, </institution><institution>Case Medical Center, </institution></institution-wrap>Cleveland, 44106 Ohio USA </aff>
          <aff id="Aff69"><label>69</label><institution-wrap><institution-id institution-id-type="GRID">grid.414844.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 0436 8670</institution-id><institution>Chirugische Klinik, Israelitisches Krankenhaus, </institution></institution-wrap>Hamburg, 22297 Germany </aff>
          <aff id="Aff70"><label>70</label><institution-wrap><institution-id institution-id-type="GRID">grid.421489.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 4656 9526</institution-id><institution>SRA International, </institution></institution-wrap>Fairfax, Virginia 22033 USA </aff>
          <aff id="Aff71"><label>71</label><institution-wrap><institution-id institution-id-type="GRID">grid.94365.3d</institution-id><institution-id institution-id-type="ISNI">0000 0001 2297 5165</institution-id><institution>The Cancer Genome Atlas Program Office, National Cancer Institute, National Institutes of Health, </institution></institution-wrap>Bethesda, 20892 Maryland USA </aff>
          <aff id="Aff72"><label>72</label><institution-wrap><institution-id institution-id-type="GRID">grid.48336.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8075</institution-id><institution>Center for Biomedical Informatics and Information Technology (CBIIT), National Cancer Institute, National Institutes of Health, </institution></institution-wrap>Rockville, 20852 Maryland USA </aff>
          <aff id="Aff73"><label>73</label>Scimentis, LLC, Statham, 30666 Georgia USA </aff>
          <aff id="Aff74"><label>74</label>MLF Consulting, Arlington, 02474 Massachusetts USA </aff>
          <aff id="Aff75"><label>75</label><institution-wrap><institution-id institution-id-type="GRID">grid.280128.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2233 9230</institution-id><institution>National Human Genome Research Institute, National Institutes of Health, </institution></institution-wrap>Bethesda, 20892 Maryland USA </aff>
        </contrib-group>
        <pub-date pub-type="epub">
          <day>18</day>
          <month>7</month>
          <year>2012</year>
        </pub-date>
        <pub-date pub-type="ppub">
          <year>2012</year>
        </pub-date>
        <volume>487</volume>
        <issue>7407</issue>
        <issue-id pub-id-type="pmc-issue-id">381929</issue-id>
        <fpage>330</fpage>
        <lpage>337</lpage>
        <history>
          <date date-type="received">
            <day>15</day>
            <month>11</month>
            <year>2011</year>
          </date>
          <date date-type="accepted">
            <day>22</day>
            <month>5</month>
            <year>2012</year>
          </date>
        </history>
        <pub-history>
          <event event-type="pmc-release">
            <date>
              <day>18</day>
              <month>07</month>
              <year>2012</year>
            </date>
          </event>
          <event event-type="pmc-live">
            <date>
              <day>19</day>
              <month>01</month>
              <year>2013</year>
            </date>
          </event>
          <event event-type="pmc-last-change">
            <date iso-8601-date="2024-02-08 18:25:11.160">
              <day>08</day>
              <month>02</month>
              <year>2024</year>
            </date>
          </event>
          <event event-type="pmc-version" specific-use="live">
            <article-id pub-id-type="pmcaiid">3401966</article-id>
            <article-id pub-id-type="doi">10.1038/nature11252</article-id>
            <article-id pub-id-type="manuscript-id">NIHMS379461</article-id>
            <article-version>1</article-version>
            <pub-date>
              <day>18</day>
              <month>07</month>
              <year>2012</year>
            </pub-date>
          </event>
          <event event-type="pmc-version" specific-use="live">
            <article-id pub-id-type="pmcaiid">8127819</article-id>
            <article-id pub-id-type="doi">10.1038/nature11252</article-id>
            <article-version>2</article-version>
            <pub-date>
              <day>18</day>
              <month>07</month>
              <year>2012</year>
            </pub-date>
          </event>
        </pub-history>
        <permissions>
          <copyright-statement>© The Author(s) 2012</copyright-statement>
          <license>
            <ali:license_ref specific-use="textmining" content-type="ccbyncsalicense">https://creativecommons.org/licenses/by-nc-sa/3.0/</ali:license_ref>
            <license-p>This article is distributed under the terms of the Creative Commons Attribution-Non-Commercial-Share Alike licence (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-sa/3.0/">http://creativecommons.org/licenses/by-nc-sa/3.0/</ext-link>), which permits distribution, and reproduction in any medium, provided the original author and source are credited. This licence does not permit commercial exploitation, and derivative works must be licensed under the same or similar licence.</license-p>
          </license>
        </permissions>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="41586_2012_Article_BFnature11252.pdf"/>
        <abstract id="Abs1">
          <p>To characterize somatic alterations in colorectal carcinoma, we conducted a genome-scale analysis of 276 samples, analysing exome sequence, DNA copy number, promoter methylation and messenger RNA and microRNA expression. A subset of these samples (97) underwent low-depth-of-coverage whole-genome sequencing. In total, 16% of colorectal carcinomas were found to be hypermutated: three-quarters of these had the expected high microsatellite instability, usually with hypermethylation and <italic toggle="yes">MLH1</italic> silencing, and one-quarter had somatic mismatch-repair gene and polymerase ε (<italic toggle="yes">POLE</italic>) mutations. Excluding the hypermutated cancers, colon and rectum cancers were found to have considerably similar patterns of genomic alteration. Twenty-four genes were significantly mutated, and in addition to the expected <italic toggle="yes">APC</italic>, <italic toggle="yes">TP53</italic>, <italic toggle="yes">SMAD4</italic>, <italic toggle="yes">PIK3CA</italic> and <italic toggle="yes">KRAS</italic> mutations, we found frequent mutations in <italic toggle="yes">ARID1A</italic>, <italic toggle="yes">SOX9</italic> and <italic toggle="yes">FAM123B.</italic> Recurrent copy-number alterations include potentially drug-targetable amplifications of <italic toggle="yes">ERBB2</italic> and newly discovered amplification of <italic toggle="yes">IGF2</italic>. Recurrent chromosomal translocations include the fusion of <italic toggle="yes">NAV2</italic> and WNT pathway member <italic toggle="yes">TCF7L1</italic>. Integrative analyses suggest new markers for aggressive colorectal carcinoma and an important role for <italic toggle="yes">MYC</italic>-directed transcriptional activation and repression.</p>
          <sec>
            <title>Supplementary information</title>
            <p>The online version of this article (doi:10.1038/nature11252) contains supplementary material, which is available to authorized users.</p>
          </sec>
        </abstract>
        <abstract id="Abs2" abstract-type="web-summary">
          <p>The Cancer Genome Atlas consortium reports on their genome-wide characterization of somatic alterations in colorectal cancer; in addition to revealing a remarkably consistent pattern of genomic alteration, with 24 genes being significantly mutated, the study identifies new targets for therapeutic intervention and suggests an important role for MYC-directed transcriptional activation and repression.</p>
          <sec>
            <title>Supplementary information</title>
            <p>The online version of this article (doi:10.1038/nature11252) contains supplementary material, which is available to authorized users.</p>
          </sec>
        </abstract>
        <abstract id="Abs3" abstract-type="LongSummary">
          <title>Mutations associated with colorectal cancer</title>
          <p>The Cancer Genome Atlas consortium reports on their genome-wide characterization of somatic alterations in colorectal carcinoma. Combined analysis of exome sequence data, DNA copy number, promoter methylation, messenger RNA and microRNA expression, as well as low-coverage whole-genome sequencing reveal that 16% of these carcinomas have hypermutation. Of these, three-quarters have the expected high microsatellite instability, but the rest have somatic mismatch repair gene mutations. The data reveal a remarkably consistent pattern of genomic alteration, with 24 genes being significantly mutated. As well as identifying new biomarkers for aggressive colorectal carcinoma, the data imply an important role for <italic toggle="yes">MYC</italic>-directed transcriptional activation and repression.</p>
          <sec>
            <title>Supplementary information</title>
            <p>The online version of this article (doi:10.1038/nature11252) contains supplementary material, which is available to authorized users.</p>
          </sec>
        </abstract>
        <kwd-group kwd-group-type="npg-subject">
          <title>Subject terms</title>
          <kwd>Genomics</kwd>
          <kwd>Chromosome abnormality</kwd>
          <kwd>DNA sequencing</kwd>
          <kwd>Colorectal cancer</kwd>
        </kwd-group>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-status-qastatus</meta-name>
            <meta-value>0</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-live</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-embargo</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-released</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-open-access</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-olf</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-manuscript</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-legally-suppressed</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-pdf</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-supplement</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-pdf-only</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-suppress-copyright</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-real-version</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-scanned-article</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-preprint</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-in-epmc</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>issue-copyright-statement</meta-name>
            <meta-value>© Springer Nature Limited 2012</meta-value>
          </custom-meta>
        </custom-meta-group>
      </article-meta>
    </front>
    <body>
      <sec id="Sec1">
        <title>Main</title>
        <p>The Cancer Genome Atlas project plans to profile genomic changes in 20 different cancer types and has so far published results on two cancer types<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. We now present results from multidimensional analyses of human colorectal carcinoma (CRC).</p>
        <p>CRC is an important contributor to cancer mortality and morbidity. The distinction between the colon and the rectum is largely anatomical, but it has both surgical and radiotherapeutic management implications and it may have an impact on prognosis. Most investigators divide CRC biologically into those with microsatellite instability (MSI; located primarily in the right colon and frequently associated with the CpG island methylator phenotype (CIMP) and hyper-mutation) and those that are microsatellite stable but chromosomally unstable.</p>
        <p>A rich history of investigations (for a review see ref. <xref ref-type="bibr" rid="CR3">3</xref>) has uncovered several critical genes and pathways important in the initiation and progression of CRC (ref. <xref ref-type="bibr" rid="CR3">3</xref>). These include the WNT, RAS−MAPK, PI3K, TGF-β, P53 and DNA mismatch-repair pathways. Large-scale sequencing analyses<sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref></sup> have identified numerous recurrently mutated genes and a recurrent chromosomal translocation. Despite this background, we have not had a fully integrated view of the genetic and genomic changes and their significance for colorectal tumorigenesis. Further insight into these changes may enable deeper understanding of the pathophysiology of CRC and may identify potential therapeutic targets.</p>
      </sec>
      <sec id="Sec2">
        <title>Results</title>
        <p>Tumour and normal pairs were analysed by different platforms. The specific numbers of samples analysed by each platform are shown in <xref rid="MOESM69" ref-type="media">Supplementary Table 1</xref>.</p>
        <sec id="Sec3">
          <title>Exome-sequence analysis</title>
          <p>To define the mutational spectrum, we performed exome capture DNA sequencing on 224 tumour and normal pairs (all mutations are listed in <xref rid="MOESM69" ref-type="media">Supplementary Table 2</xref>). Sequencing achieved &gt;20-fold coverage of at least 80% of targeted exons. The somatic mutation rates varied considerably among the samples. Some had mutation rates of &lt;1 per 10<sup>6</sup> bases, whereas a few had mutations rates of &gt;100 per 10<sup>6</sup>. We separated cases (84%) with a mutation rate of &lt;8.24 per 10<sup>6</sup> (median number of non-silent mutations, 58) and those with mutation rates of &gt;12 per 10<sup>6</sup> (median number of total mutations, 728), which we designated as hypermutated (<xref rid="Fig1" ref-type="fig">Fig. 1</xref>).<fig id="Fig1" position="float" orientation="portrait"><label>Figure 1</label><caption><title><bold>Mutation frequencies in human CRC.</bold></title><p><bold>a</bold>, Mutation frequencies in each of the tumour samples from 224 patients. Note a clear separation of hypermutated and non-hypermutated samples. Red, MSI high, CIMP high or MLH1 silenced; light blue, MSI low, or CIMP low; black, rectum; white, colon; grey, no data. Inset, mutations in mismatch-repair genes and <italic toggle="yes">POLE</italic> among the hypermutated samples. The order of the samples is the same as in the main graph. <bold>b</bold>, Significantly mutated genes in hypermutated and non-hypermutated tumours. Blue bars represent genes identified by the MutSig algorithm and black bars represent genes identified by manual examination of sequence data.</p><p>
<xref rid="MOESM64" ref-type="media">PowerPoint slide</xref>
</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e3594" position="float" orientation="portrait" xlink:href="41586_2012_BFnature11252_Fig1_HTML.jpg"/></fig></p>
          <p>To assess the basis for the considerably different mutation rates, we evaluated MSI<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> and mutations in the DNA mismatch-repair pathway<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR10">10</xref></sup> genes <italic toggle="yes">MLH1</italic>, <italic toggle="yes">MLH3</italic>, <italic toggle="yes">MSH2</italic>, <italic toggle="yes">MSH3</italic>, <italic toggle="yes">MSH6</italic> and <italic toggle="yes">PMS2</italic>. Among the 30 hypermutated tumours with a complete data set, 23 (77%) had high levels of MSI (MSI-H). Included in this group were 19 tumours with <italic toggle="yes">MLH1</italic> methylation, 17 of which had CIMP. By comparison, the remaining seven hypermutated tumours, including the six with the highest mutation rates, lacked MSI-H, CIMP or MLH1 methylation but usually had somatic mutations in one or more mismatch-repair genes or <italic toggle="yes">POLΕ</italic> aberrations seen rarely in the non-hypermutated tumours (<xref rid="Fig1" ref-type="fig">Fig. 1</xref>).</p>
        </sec>
        <sec id="Sec4">
          <title>Gene mutations</title>
          <p>Overall, we identified 32 somatic recurrently mutated genes (defined by MutSig<sup><xref ref-type="bibr" rid="CR11">11</xref></sup> and manual curation) in the hypermutated and non-hypermutated cancers (<xref rid="Fig1" ref-type="fig">Fig. 1b</xref>). After removal of non-expressed genes, there were 15 and 17 in the hypermutated and non-hypermutated cancers, respectively (<xref rid="Fig1" ref-type="fig">Fig. 1b</xref>; for a complete list see <xref rid="MOESM69" ref-type="media">Supplementary Table 3</xref>). Among the non-hypermutated tumours, the eight most frequently mutated genes were <italic toggle="yes">APC</italic>, <italic toggle="yes">TP53</italic>, <italic toggle="yes">KRAS</italic>, <italic toggle="yes">PIK3CA</italic>, <italic toggle="yes">FBXW7</italic>, <italic toggle="yes">SMAD4</italic>, <italic toggle="yes">TCF7L2</italic> and <italic toggle="yes">NRAS</italic>. As expected, the mutated <italic toggle="yes">KRAS</italic> and <italic toggle="yes">NRAS</italic> genes usually had oncogenic codon 12 and 13 or codon 61 mutations, whereas the remaining genes had inactivating mutations. <italic toggle="yes">CTNNB1</italic>, <italic toggle="yes">SMAD2</italic>, <italic toggle="yes">FAM123B</italic> (also known as <italic toggle="yes">WTX</italic>) and <italic toggle="yes">SOX9</italic> were also mutated frequently. <italic toggle="yes">FAM123B</italic> is an X-linked negative regulator of WNT signalling<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>, and virtually all of its mutations were loss of function. Mutations in <italic toggle="yes">SOX9</italic>, a gene important for cell differentiation in the intestinal stem cell niche<sup><xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR14">14</xref></sup>, have not been associated previously with human cancer, but all nine mutated alleles in the non-hypermutated CRCs were frameshift or nonsense mutations. Tumour-suppressor genes <italic toggle="yes">ATM</italic> and <italic toggle="yes">ARID1A</italic> also had a disproportionately high number of frameshift or nonsense mutations. <italic toggle="yes">ARID1A</italic> mutations have recently been reported in CRC and many other cancers<sup><xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR16">16</xref></sup>.</p>
          <p>In the hypermutated tumours, <italic toggle="yes">ACVR2A</italic>, <italic toggle="yes">APC</italic>, <italic toggle="yes">TGFBR2</italic>, <italic toggle="yes">MSH3</italic>, <italic toggle="yes">MSH6</italic>, <italic toggle="yes">SLC9A9</italic> and <italic toggle="yes">TCF7L2</italic> were frequent targets of mutation (<xref rid="Fig1" ref-type="fig">Fig. 1b</xref>), along with mostly <italic toggle="yes">BRAF(V600E)</italic> mutations. However, two genes that were frequently mutated in the non-hypermutated cancers were significantly less frequently mutated in hypermutated tumours: <italic toggle="yes">TP53</italic> (60 versus 20%, <italic toggle="yes">P</italic> &lt; 0.0001) and <italic toggle="yes">APC</italic> (81% versus 51%, <italic toggle="yes">P</italic> = 0.0023; both Fisher’s exact test). Other genes, including <italic toggle="yes">TGFBR2</italic>, were mutated recurrently in the hypermutated cancers, but not in the non-hypermutated samples. These findings indicate that hypermutated and non-hypermutated tumours progress through different sequences of genetic events.</p>
          <p>As expected, hypermutated tumours with MLH1 silencing and MSI-H showed additional differences in the mutational profile. When we specifically examined 28 genes with long mononucleotide repeats in their coding sequences, we found that the rate of frameshift mutation was 3.6-fold higher than the rate of such mutations in hypermutated tumours without MLH1 silencing and 50-fold higher than that in non-hypermethylated tumours (<xref rid="MOESM69" ref-type="media">Supplementary Table 2</xref>).</p>
        </sec>
        <sec id="Sec5">
          <title>Mutation rate and methylation patterns</title>
          <p>As mentioned above, patients with colon and rectal tumours are managed differently<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, and epidemiology also highlights differences between the two<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. An initial integrative analysis of MSI status, somatic copy-number alterations (SCNAs), CIMP status and gene-expression profiles of 132 colonic and 62 rectal tumours enabled us to examine possible biological differences between tumours in the two locations. Among the non-hypermutated tumours, however, the overall patterns of changes in copy number, CIMP, mRNA and miRNA were indistinguishable between colon and rectal carcinomas (<xref rid="Fig2" ref-type="fig">Fig. 2</xref>). On the basis of this result, we merged the two for all subsequent analyses.<fig id="Fig2" position="float" orientation="portrait"><label>Figure 2</label><caption><title><bold>Integrative analysis of genomic changes in 195 CRCs.</bold></title><p>Hypermutated tumours have near-diploid genomes and are highly enriched for hypermethylation, CIMP expression phenotype and <italic toggle="yes">BRAF(V600E)</italic> mutations. Non-hypermutated tumours originating from different sites are virtually indistinguishable from each other on the basis of their copy-number alteration patterns, DNA methylation or gene-expression patterns. Copy-number changes of the 22 autosomes are shown in shades of red for copy-number gains and shades of blue for copy-number losses.</p><p>
<xref rid="MOESM65" ref-type="media">PowerPoint slide</xref>
</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e3825" position="float" orientation="portrait" xlink:href="41586_2012_BFnature11252_Fig2_HTML.jpg"/></fig></p>
          <p>Unsupervised clustering of the promoter DNA methylation profiles of 236 colorectal tumours identified four subgroups (<xref rid="MOESM69" ref-type="media">Supplementary Fig. 1</xref> and <xref rid="MOESM69" ref-type="media">Supplementary Methods</xref>). Two of the clusters contained tumours with elevated rates of methylation and were classified as CIMP high and CIMP low, as previously described<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. The two non-CIMP clusters were predominantly from tumours that were non-hypermutated and derived from different anatomic locations. mRNA expression profiles separated the colorectal tumours into three distinct clusters (<xref rid="MOESM69" ref-type="media">Supplementary Fig. 2</xref>). One significantly overlapped with CIMP-high tumours (<italic toggle="yes">P</italic> = 3 × 10<sup>−12</sup>) and was enriched with hypermutated tumours, and the other two clusters did not correspond with any group in the methylation data. Analysis of miRNA expression by unsupervised clustering (<xref rid="MOESM69" ref-type="media">Supplementary Fig. 3</xref>) identified no clear distinctions between rectal cancers and non-hypermethylated colon cancers.</p>
        </sec>
        <sec id="Sec6">
          <title>Chromosomal and sub-chromosomal changes</title>
          <p>In total, 257 tumours were profiled for SCNAs with Affymetrix SNP 6.0 arrays. Of these tumours, 97 were also analysed by low-depth-of-coverage (low-pass) whole-genome sequencing. As expected, the hypermutated tumours had far fewer SCNAs (<xref rid="Fig2" ref-type="fig">Fig. 2</xref>). No difference was found between microsatellite-stable and -unstable hypermutated tumours (<xref rid="MOESM69" ref-type="media">Supplementary Fig. 4</xref>). We used the GISTIC algorithm<sup><xref ref-type="bibr" rid="CR19">19</xref></sup> to identify probable gene targets of focal alterations. There were several previously well-defined arm-level changes, including gains of 1q, 7p and q, 8p and q, 12q, 13q, 19q, and 20p and q (ref. <xref ref-type="bibr" rid="CR6">6</xref>). (<xref rid="MOESM69" ref-type="media">Supplementary Fig. 4</xref> and <xref rid="MOESM69" ref-type="media">Supplementary Table 4</xref>). Significantly deleted chromosome arms were 18p and q (including <italic toggle="yes">SMAD4</italic>) in 66% of the tumours and 17p and q (including <italic toggle="yes">TP53</italic>) in 56%. Other significantly deleted chromosome arms were 1p, 4q, 5q, 8p, 14q, 15q, 20p and 22q.</p>
          <p>We identified 28 recurrent deletion peaks (<xref rid="MOESM69" ref-type="media">Supplementary Fig. 4</xref> and <xref rid="MOESM69" ref-type="media">Supplementary Table 4</xref>), including the genes <italic toggle="yes">FHIT</italic>, RBFOX1 and <italic toggle="yes">WWOX</italic> with large genomic footprints located in potentially fragile sites of the genome, in near-diploid hypermutated tumours. Other focal deletions involved tumour-suppressor genes such as <italic toggle="yes">SMAD4</italic>, <italic toggle="yes">APC</italic>, <italic toggle="yes">PTEN</italic> and <italic toggle="yes">SMAD3</italic>. A significant focal deletion of 10p25.2 spanned four genes, including <italic toggle="yes">TCF7L2</italic>, which was also frequently mutated in our data set. A gene fusion between adjacent genes <italic toggle="yes">VTI1A</italic> and <italic toggle="yes">TCF7L2</italic> through an interstitial deletion was found in 3% of CRCs and is required for survival of CRC cells bearing the translocation<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>.</p>
          <p>There were 17 regions of significant focal amplification (<xref rid="MOESM69" ref-type="media">Supplementary Table 4</xref>). Some of these were superimposed on broad gains of chromosome arms, and included a peak at 13q12.13 near the peptidase-coding gene <italic toggle="yes">USP12</italic> and at ∼500 kb distal to the CRC candidate oncogene <italic toggle="yes">CDK8</italic>; an adjacent peak at 13q12; a peak containing <italic toggle="yes">KLF5</italic> at 13q22.1; and a peak at 20q13.12 adjacent to <italic toggle="yes">HNF4A</italic>. Peaks on chromosome 8 included 8p12 (which contains the histone methyl-transferase-coding gene <italic toggle="yes">WHSC1L1</italic>, adjacent to <italic toggle="yes">FGFR1</italic>) and 8q24 (which contains <italic toggle="yes">MYC</italic>). An amplicon at 17q21.1, found in 4% of the tumours, contains seven genes, including the tyrosine kinase <italic toggle="yes">ERBB2</italic>. <italic toggle="yes">ERBB2</italic> amplifications have been described in colon, breast and gastro–oesophageal tumours, and breast and gastric cancers bearing these amplifications have been treated effectively with the anti-ERBB2 antibody trastuzumab<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR22">22</xref></sup>.</p>
          <p>One of the most common focal amplifications, found in 7% of the tumours, is the gain of a 100–150-kb region of the chromosome arm 11p15.5. It contains genes encoding insulin (<italic toggle="yes">INS</italic>), insulin-like growth factor 2 (<italic toggle="yes">IGF2</italic>) and tyrosine hydroxylase (<italic toggle="yes">TH</italic>), as well as <italic toggle="yes">miR-483</italic>, which is embedded within <italic toggle="yes">IGF2</italic> (<xref rid="Fig3" ref-type="fig">Fig. 3a</xref>). We found elevated expression of <italic toggle="yes">IGF2</italic> and <italic toggle="yes">miR-483</italic> but not of <italic toggle="yes">INS</italic> and <italic toggle="yes">TH</italic> (<xref rid="Fig3" ref-type="fig">Fig. 3b, c</xref>). Immediately adjacent to the amplified region is <italic toggle="yes">ASCL2</italic>, a transcription factor active in specifying intestinal stem-cell fate<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. Although <italic toggle="yes">ASCL2</italic> has been implicated as a target of amplification in CRC<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>, it was consistently outside the region of amplification and its expression was not correlated with copy-number changes. These observations suggest that <italic toggle="yes">IGF2</italic> and miR-483 are candidate functional targets of 11p15.5 amplification. <italic toggle="yes">IGF2</italic> overexpression through loss of imprinting has been implicated in the promotion of CRC<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR27">27</xref></sup>. MiR-483 may also have a role in CRC pathogenesis<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>.<fig id="Fig3" position="float" orientation="portrait"><label>Figure 3</label><caption><title><bold>Copy-number changes and structural aberrations in CRC.</bold></title><p><bold>a</bold>, Focal amplification of 11p15.5. Segmented DNA copy-number data from single-nucleotide polymorphism (SNP) arrays and low-pass whole-genome sequencing (WGS) are shown. Each row represents a patient; amplified regions are shown in red. <bold>b</bold>, Correlation of expression levels with copy-number changes for <italic toggle="yes">IGF2</italic> and <italic toggle="yes">miR-483</italic>. <bold>c</bold>, <italic toggle="yes">IGF2</italic> amplification and overexpression are mutually exclusive of alterations in PI3K signalling-related genes. <bold>d</bold>, Recurrent <italic toggle="yes">NAV2</italic>–<italic toggle="yes">TCF7L2</italic> fusions. The structure of the two genes, locations of the breakpoints leading to the translocation and circular representations of all rearrangements in tumours with a fusion are shown. Red line lines represent the <italic toggle="yes">NAV2</italic>–<italic toggle="yes">TCF7L2</italic> fusions and black lines represent other rearrangements. The inner ring represents copy-number changes (blue denotes loss, pink denotes gain).</p><p>
<xref rid="MOESM66" ref-type="media">PowerPoint slide</xref>
</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e4090" position="float" orientation="portrait" xlink:href="41586_2012_BFnature11252_Fig3_HTML.jpg"/></fig></p>
          <p>A subset of tumours without <italic toggle="yes">IGF2</italic> amplification (15%) also had considerably higher levels of <italic toggle="yes">IGF2</italic> gene expression (as much as a 100-fold increase), an effect not attributable to methylation changes at the <italic toggle="yes">IGF2</italic> promoter. To assess the context of <italic toggle="yes">IGF2</italic> amplification/overexpression, we systematically searched for mutually exclusive genomic events using the MEMo method<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. We found a pattern of near exclusivity (corrected <italic toggle="yes">P</italic> &lt; 0.01) of <italic toggle="yes">IGF2</italic> overexpression with genomic events known to activate the PI3K pathway (mutations of <italic toggle="yes">PIK3CA</italic> and <italic toggle="yes">PIK3R1</italic> or deletion/mutation of <italic toggle="yes">PTEN</italic>; <xref rid="Fig3" ref-type="fig">Fig. 3c</xref> and <xref rid="MOESM69" ref-type="media">Supplementary Table 5</xref>). The <italic toggle="yes">IRS2</italic> gene, encoding a protein linking IGF1R (the receptor for IGF2) with PI3K, is on chromosome 13, which is frequently gained in CRC. The cases with the highest <italic toggle="yes">IRS2</italic> expression were mutually exclusive of the cases with <italic toggle="yes">IGF2</italic> overexpression (<italic toggle="yes">P</italic> = 0.04) and also lacked mutations in the PI3K pathway (<italic toggle="yes">P</italic> = 0.0001; <xref rid="Fig3" ref-type="fig">Fig. 3c</xref>). These results strongly suggest that the IGF2–IGF1R–IRS2 axis signals to PI3K in CRC and imply that therapeutic targeting of the pathway could act to block PI3K activity in this subset of patients.</p>
        </sec>
        <sec id="Sec7">
          <title>Translocations</title>
          <p>To identify new chromosomal translocations, we performed low-pass, paired-end, whole-genome sequencing on 97 tumours with matched normal samples. In each case we achieved sequence coverage of ∼3–4-fold and a corresponding physical coverage of 7.5–10-fold. Despite the low genome coverage, we detected 250 candidate interchromosomal translocation events (range, 0–10 per tumour). Among these events, 212 had one or both breakpoints in an intergenic region, whereas the remaining 38 juxtaposed coding regions of two genes in putative fusion events, of which 18 were predicted to code for in-frame events (<xref rid="MOESM69" ref-type="media">Supplementary Table 6</xref>). We found three separate cases in which the first two exons of the <italic toggle="yes">NAV2</italic> gene on chromosome 11 are joined with the 3′ coding portion of <italic toggle="yes">TCF7L1</italic> on chromosome 2 (<xref rid="MOESM69" ref-type="media">Supplementary Fig. 5</xref>). <italic toggle="yes">TCF7L1</italic> encodes TCF3, a member of the TCF/LEF class of transcription factors that heterodimerize with nuclear β-catenin to enable β-catenin-mediated transcriptional regulation. Intriguingly, in all three cases, the predicted structure of the NAV2–TCF7L1 fusion protein lacks the TCF3 β-catenin-binding domain. This translocation is similar to another recurrent translocation identified in CRC, a fusion in which the amino terminus of VTI1A is joined to TCF4, which is encoded by <italic toggle="yes">TCF7L2</italic>, a homologue of <italic toggle="yes">TCF7L1</italic> that is deleted or mutated in 12% of non-hypermutated tumours<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. We also observed 21 cases of translocation involving <italic toggle="yes">TTC28</italic> located on chromosome 22 (<xref rid="MOESM69" ref-type="media">Supplementary Table 6</xref>). In all cases the fusions predict inactivation of <italic toggle="yes">TTC28</italic>, which has been identified as a target of P53 and an inhibitor of tumour cell growth<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. Eleven of the 19 (58%) gene–gene translocations were validated by obtaining PCR products or, in some cases, sequencing the junction fragments (<xref rid="MOESM69" ref-type="media">Supplementary Fig. 5</xref>).</p>
        </sec>
        <sec id="Sec8">
          <title>Altered pathways in CRC</title>
          <p>Integrated analysis of mutations, copy number and mRNA expression changes in 195 tumours with complete data enriched our understanding of how some well-defined pathways are deregulated. We grouped samples by hypermutation status and identified recurrent alterations in the WNT, MAPK, PI3K, TGF-β and p53 pathways (<xref rid="Fig4" ref-type="fig">Fig. 4</xref>, <xref rid="MOESM69" ref-type="media">Supplementary Fig. 6</xref> and <xref rid="MOESM69" ref-type="media">Supplementary Table 1</xref>).<fig id="Fig4" position="float" orientation="portrait"><label>Figure 4</label><caption><title><bold>Diversity and frequency of genetic changes leading to deregulation of signalling pathways in CRC.</bold></title><p>Non-hypermutated (nHM; <italic toggle="yes">n</italic> = 165) and hypermutated (HM; <italic toggle="yes">n</italic> = 30) samples with complete data were analysed separately. Alterations are defined by somatic mutations, homozygous deletions, high-level focal amplifications, and, in some cases, by significant up- or downregulation of gene expression (<italic toggle="yes">IGF2</italic>, <italic toggle="yes">FZD10</italic>, <italic toggle="yes">SMAD4</italic>). Alteration frequencies are expressed as a percentage of all cases. Red denotes activated genes and blue denotes inactivated genes. Bottom panel shows for each sample if at least one gene in each of the five pathways described in this figure is altered.</p><p>
<xref rid="MOESM67" ref-type="media">PowerPoint slide</xref>
</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e4244" position="float" orientation="portrait" xlink:href="41586_2012_BFnature11252_Fig4_HTML.jpg"/></fig></p>
          <p>We found that the WNT signalling pathway was altered in 93% of all tumours, including biallelic inactivation of <italic toggle="yes">APC</italic> (<xref rid="MOESM69" ref-type="media">Supplementary Table 7</xref>) or activating mutations of <italic toggle="yes">CTNNB1</italic> in ∼80% of cases. There were also mutations in <italic toggle="yes">SOX9</italic> and mutations and deletions in <italic toggle="yes">TCF7L2</italic>, as well as the DKK family members and <italic toggle="yes">AXIN2</italic>, <italic toggle="yes">FBXW7</italic> (<xref rid="MOESM69" ref-type="media">Supplementary Fig. 7</xref>), <italic toggle="yes">ARID1A</italic> and <italic toggle="yes">FAM123B</italic> (the latter is a negative regulator of WNT–β-catenin signalling<sup><xref ref-type="bibr" rid="CR12">12</xref></sup> found mutated in Wilms’ tumour<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>). A few mutations in <italic toggle="yes">FAM123B</italic> have previously been described in CRC<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. SOX9 has been suggested to have a role in cancer, but no mutations have previously been described. The WNT receptor frizzled (<italic toggle="yes">FZD10</italic>) was overexpressed in ∼17% of samples, in some instances at levels of 100× normal. Altogether, we found 16 different altered WNT pathway genes, confirming the importance of this pathway in CRC. Interestingly, many of these alterations were found in tumours that harbour <italic toggle="yes">APC</italic> mutations, suggesting that multiple lesions affecting the WNT signalling pathway confer selective advantage.</p>
          <p>Genetic alterations in the PI3K and RAS–MAPK pathways are common in CRC. In addition to <italic toggle="yes">IGF2</italic> and <italic toggle="yes">IRS2</italic> overexpression, we found mutually exclusive mutations in <italic toggle="yes">PIK3R1</italic> and <italic toggle="yes">PIK3CA</italic> as well as deletions in <italic toggle="yes">PTEN</italic> in 2%, 15% and 4% of non-hypermutated tumours, respectively. We found that 55% of non-hypermutated tumours have alterations in <italic toggle="yes">KRAS</italic>, <italic toggle="yes">NRAS</italic> or <italic toggle="yes">BRAF</italic>, with a significant pattern of mutual exclusivity (<xref rid="MOESM69" ref-type="media">Supplementary Fig. 6</xref> and <xref rid="MOESM69" ref-type="media">Supplementary Table 1</xref>). We also evaluated mutations in the erythroblastic leukemia viral oncogene homolog (ERBB) family of receptors because of the translational relevance of such mutations. Mutations or amplifications in one of the four ERBB family genes are present in 22 out of 165 (13%) non-hypermutated and 16 out of 30 (53%) hypermutated cases. Some of the mutations are listed in the COSMIC database<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>, suggesting a functional role. Intriguingly, recurrent <italic toggle="yes">ERBB2(V842I)</italic> and <italic toggle="yes">ERBB3(V104M)</italic> mutations were found in four and two non-hypermutated cases, respectively. Mutations and focal amplifications of <italic toggle="yes">ERBB2</italic> (<xref rid="MOESM69" ref-type="media">Supplementary Fig. 6</xref>) should be evaluated as predictors of response to agents that target those receptors. We observed co-occurrence of alterations involving the RAS and PI3K pathways in one-third of tumours (<xref rid="Fig4" ref-type="fig">Fig. 4</xref>; <italic toggle="yes">P</italic> = 0.039, Fisher’s exact test). These results indicate that simultaneous inhibition of the RAS and PI3K pathways may be required to achieve therapeutic benefit.</p>
          <p>The TGF-β signalling pathway is known to be deregulated in CRC and other cancers<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. We found genomic alterations in <italic toggle="yes">TGFBR1</italic>, <italic toggle="yes">TGFBR2</italic>, <italic toggle="yes">ACVR2A</italic>, <italic toggle="yes">ACVR1B</italic>, <italic toggle="yes">SMAD2</italic>, <italic toggle="yes">SMAD3</italic> and <italic toggle="yes">SMAD4</italic> in 27% of the non-hypermutated and 87% of the hypermutated tumours. We also evaluated the p53 pathway, finding alterations in <italic toggle="yes">TP53</italic> in 59% of non-hypermutated cases (mostly biallelic; <xref rid="MOESM69" ref-type="media">Supplementary Table 8</xref>) and alterations in ATM, a kinase that phosphorylates and activates P53 after DNA damage, in 7%. Alterations in these two genes showed a trend towards mutual exclusivity (<italic toggle="yes">P</italic> = 0.016) (<xref rid="Fig4" ref-type="fig">Fig. 4</xref>, <xref rid="MOESM69" ref-type="media">Supplementary Fig. 6</xref> and <xref rid="MOESM69" ref-type="media">Supplementary Table 1</xref>).</p>
          <p>We integrated copy number, gene expression, methylation and pathway data using the PARADIGM software platform<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. The analysis showed a number of new characteristics of CRC (<xref rid="Fig5" ref-type="fig">Fig. 5a</xref>). For example, despite the diversity in anatomical origin or mutation levels, nearly 100% of these tumours have changes in MYC transcriptional targets, both those promoted by and those inhibited by MYC. These findings are consistent with patterns deduced from genetic alterations (<xref rid="Fig4" ref-type="fig">Fig. 4</xref>) and suggest an important role for <italic toggle="yes">MYC</italic> in CRC. The analysis also identified several gene networks altered across all tumour samples and those with differential alterations in hypermutated versus non-hypermutated samples (<xref rid="MOESM69" ref-type="media">Supplementary Table 7</xref>, Supplementary Data on the Cancer Genome Atlas publication webpage).<fig id="Fig5" position="float" orientation="portrait"><label>Figure 5</label><caption><title><bold>Integrative analyses of multiple data sets.</bold></title><p><bold>a</bold>, Clustering of genes and pathways affected in colon and rectum tumours deduced by PARADIGM analysis. Blue denotes under-expressed relative to normal and red denotes overexpressed relative to normal. Some of the pathways deduced by this method are shown on the right. NHEJ, non-homologous end joining. <bold>b</bold>, Gene-expression signatures and SCNAs associated with tumour aggression. Molecular signatures (rows) that show a statistically significant association with tumour aggressiveness according to selected clinical assays (columns) are shown in colour, with red indicating markers of tumour aggressiveness and blue indicating the markers of less-aggressive tumours. Significance is based on the combined <italic toggle="yes">P</italic> value from the weighted Fisher’s method, corrected for multiple testing. Colour intensity and score is in accordance with the strength of an individual clinical–molecular association, and is proportional to log<sub>10</sub>(<italic toggle="yes">P</italic>), where <italic toggle="yes">P</italic> is the <italic toggle="yes">P</italic> value for that association. To limit the vertical extent of the figure, gene-expression signatures are restricted to a combined <italic toggle="yes">P</italic> value of <italic toggle="yes">P</italic> &lt; 10<sup>−9</sup> and SCNAs to <italic toggle="yes">P</italic> &lt; 10<sup>−7</sup>, and features are shown only if they are also significant in the subset of non-MSI-H samples (the analysis was performed separately on the full data as well as on the MSI-H and non-MSI-H subgroups).</p><p>
<xref rid="MOESM68" ref-type="media">PowerPoint slide</xref>
</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e4474" position="float" orientation="portrait" xlink:href="41586_2012_BFnature11252_Fig5_HTML.jpg"/></fig></p>
          <p>Because most of the tumours used in this study were derived from a prospective collection, survival data are not available. However, the tumours can be classified as aggressive or non-aggressive on the basis of tumour stage, lymph node status, distant metastasis and vascular invasion at the time of surgery. We found numerous molecular signatures associated with tumour aggressiveness, a subset of which is shown in <xref rid="Fig5" ref-type="fig">Fig. 5b</xref>. They include specific focal amplifications and deletions, and altered gene-expression levels, including those of <italic toggle="yes">SCN5A</italic> (ref. <xref ref-type="bibr" rid="CR36">36</xref>), a reported regulator of colon cancer invasion (see <xref rid="MOESM69" ref-type="media">Supplementary Tables 10 and 11</xref> for a full list). Association with tumour aggressiveness is also observed in altered expression of miRNAs and specific somatic mutations (<italic toggle="yes">APC</italic>, <italic toggle="yes">TP53</italic>, <italic toggle="yes">PIK3CA</italic>, <italic toggle="yes">BRAF</italic> and <italic toggle="yes">FBXW7</italic>; <xref rid="MOESM69" ref-type="media">Supplementary Fig. 8b</xref>). Mutations in <italic toggle="yes">FBXW7</italic> (38 cases) and distant metastasis (32 cases) never co-occurred (<italic toggle="yes">P</italic> = 0.0019). Interestingly, a number of genomic regions have multiple molecular associations with tumour aggressiveness that manifest as clinically related genomic hotspots. Examples of this are the region 20q13.12, which includes a focal amplification and multiple genes correlating with tumour aggression, and the region 22q12.3, containing <italic toggle="yes">APOL6</italic> (ref. <xref ref-type="bibr" rid="CR37">37</xref>) (<xref rid="MOESM69" ref-type="media">Supplementary Figures 8 and 9</xref>).</p>
        </sec>
      </sec>
      <sec id="Sec9">
        <title>Discussion</title>
        <p>This comprehensive integrative analysis of 224 colorectal tumour and normal pairs provides a number of insights into the biology of CRC and identifies potential therapeutic targets. To identify possible biological differences in colon and rectum tumours, we found, in the non-hypermutated tumours irrespective of their anatomical origin, the same type of copy number, expression profile, DNA methylation and miRNA changes. Over 94% had a mutation in one or more members of the WNT signalling pathway, predominantly in <italic toggle="yes">APC</italic>. However, there were some differences between tumours from the right colon and all other sites. Hypermethylation was more common in the right colon, and three-quarters of hypermutated samples came from the same site, although not all of them had MSI (<xref rid="Fig2" ref-type="fig">Fig. 2</xref>). Why most of the hypermutated samples came from the right colon and why there are two classes of tumours at this site is not known. The origins of the colon from embryonic midgut and hindgut may provide an explanation. As the survival rate of patients with high MSI-related cancers is better and these cancers are hypermutated, mutation rate may be a better prognostic indicator.</p>
        <p>Whole-exome sequencing and integrative analysis of genomic data provided further insights into the pathways that are dysregulated in CRC. We found that 93% of non-hypermutated and 97% of hypermutated cases had a deregulated WNT signalling pathway. New findings included recurrent mutations in <italic toggle="yes">FAM123B</italic>, <italic toggle="yes">ARID1A</italic> and <italic toggle="yes">SOX9</italic> and very high levels of overexpression of the WNT ligand receptor gene <italic toggle="yes">FZD10</italic>. To our knowledge, <italic toggle="yes">SOX9</italic> has not previously been described as frequently mutated in any human cancer. <italic toggle="yes">SOX9</italic> is transcriptionally repressed by WNT signalling, and the SOX9 protein has been shown to facilitate β-catenin degradation<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. <italic toggle="yes">ARID1A</italic> is frequently mutated in gynaecological cancers and has been shown to suppress <italic toggle="yes">MYC</italic> transcription<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. Activation of WNT signalling and inactivation of the TGF-β signalling pathway are known to result in activation of MYC. Our mutational and integrative analyses emphasize the critical role of MYC in CRC. We also compared our results with other large-scale analyses<sup><xref ref-type="bibr" rid="CR6">6</xref></sup> and found many similarities and few differences in mutated genes (<xref rid="MOESM69" ref-type="media">Supplementary Table 3</xref>).</p>
        <p>Our integrated analysis revealed a diverse set of changes in TCF/LEF-encoding genes, suggesting additional roles for TCF/LEF factors in CRC beyond being passive partners for β-catenin.</p>
        <p>Our data suggest a number of therapeutic approaches to CRC. Included are WNT-signalling inhibitors and small-molecule β-catenin inhibitors, which are showing initial promise<sup><xref ref-type="bibr" rid="CR40">40</xref>,<xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR42">42</xref></sup>. We find that several proteins in the RTK–RAS and PI3K pathways, including IGF2, IGFR, ERBB2, ERBB3, MEK, AKT and MTOR could be targets for inhibition.</p>
        <p>Our analyses show that non-hypermutated adenocarcinomas of the colon and rectum are not distinguishable at the genomic level. However, tumours from the right/ascending colon were more likely to be hypermethylated and to have elevated mutation rates than were other CRCs. As has been recognized previously, activation of the WNT signalling pathway and inactivation of the TGF-β signalling pathway, resulting in increased activity of MYC, are nearly ubiquitous events in CRC. Genomic aberrations frequently target the MAPK and PI3K pathways but less frequently target receptor tyrosine kinases. In conclusion, the data presented here provide a useful resource for understanding this deadly disease and identifying possibilities for treating it in a targeted way.</p>
      </sec>
      <sec id="Sec10">
        <title>Methods Summary</title>
        <p>Tumour and normal samples were processed by either of two biospecimen core resources, and aliquots of purified nucleic acids were shipped to the genome characterization and sequencing centres (<xref rid="MOESM69" ref-type="media">Supplementary Methods</xref>). The biospecimen core resources provided sample sets in several different batches. To assess any batch effects we examined the mRNA expression, miRNA expression and DNA methylation data sets using a combination of cluster analysis, enhanced principal component analysis and analysis of variance (<xref rid="MOESM69" ref-type="media">Supplementary Methods</xref>). Although some differences among batches were detected, we did not correct them computationally because the differences were generally modest and because some of them may reflect biological phenomena (<xref rid="MOESM69" ref-type="media">Supplementary Methods</xref>).</p>
        <p>We used Affymetrix SNP 6.0 microarrays to detect copy-number alterations. A subset of samples was subjected to low-pass (2–5×) whole-genome sequencing (Illumina HiSeq), in part for detection of SCNA and chromosomal translocations<sup><xref ref-type="bibr" rid="CR43">43</xref>,<xref ref-type="bibr" rid="CR44">44</xref></sup>. Gene-expression profiles were generated using Agilent microarrays and RNA-Seq. DNA methylation data were obtained using Illumina Infinium (HumanMethylation27) arrays. DNA sequencing of coding regions was performed by exome capture followed by sequencing on the SOLiD or Illumina HiSeq platforms. Details of the analytical methods used are described in <xref rid="MOESM69" ref-type="media">Supplementary Methods</xref>.</p>
        <p>All of the primary sequence files are deposited in dbGap and all other data are deposited at the Data Coordinating Center (DCC) for public access (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://cancergenome.nih.gov/">http://cancergenome.nih.gov/</ext-link>). Data matrices and supporting data can be found at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://tcga-data.nci.nih.gov/docs/publications/coadread_2012/">http://tcga-data.nci.nih.gov/docs/publications/coadread_2012/</ext-link>. The data can also be explored through the ISB Regulome Explorer (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://explorer.cancerregulome.org/">http://explorer.cancerregulome.org/</ext-link>), Next Generation Clustered Heat Maps (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://bioinformatics.mdanderson.org/main/TCGA/Supplements/NGCHM-CRC">http://bioinformatics.mdanderson.org/main/TCGA/Supplements/NGCHM-CRC</ext-link>) and the cBio Cancer Genomics Portal (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://cbioportal.org">http://cbioportal.org</ext-link>). Descriptions of the data can be found at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://wiki.nci.nih.gov/x/j5dXAg">https://wiki.nci.nih.gov/x/j5dXAg</ext-link> and in <xref rid="MOESM69" ref-type="media">Supplementary Methods</xref>.</p>
      </sec>
      <sec sec-type="supplementary-material">
        <title>Supplementary information</title>
        <sec id="Sec11">
          <p>
<supplementary-material content-type="local-data" id="MOESM69" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41586_2012_BFnature11252_MOESM69_ESM.pdf" position="float" orientation="portrait"><caption><title>Supplementary Information</title><p>This file contains the legends for Supplementary Tables 1-12, Supplementary Tables 1-9 and Supplementary Data files 1-2, Supplementary Methods, which include 17 Figures and 2 Tables (see Contents for details) and Supplementary Figures 1-9. (PDF 8117 kb)</p></caption></media></supplementary-material>
</p>
          <p>
<supplementary-material content-type="local-data" id="MOESM70" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41586_2012_BFnature11252_MOESM70_ESM.zip" position="float" orientation="portrait"><caption><title>Supplementary Data</title><p>This file contains Supplementary Table 2. (ZIP 25458 kb)</p></caption></media></supplementary-material>
</p>
          <p>
<supplementary-material content-type="local-data" id="MOESM71" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41586_2012_BFnature11252_MOESM71_ESM.zip" position="float" orientation="portrait"><caption><title>Supplementary Data</title><p>This file contains Supplementary Tables 1 and 3-12 (ZIP 2809 kb)</p></caption></media></supplementary-material>
</p>
        </sec>
      </sec>
    </body>
    <back>
      <app-group>
        <app id="App1">
          <sec id="Sec12">
            <title>PowerPoint slides</title>
            <p>
<media xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="41586_2012_BFnature11252_MOESM64_ESM.ppt" id="MOESM64" orientation="portrait"><caption><p>PowerPoint slide for Fig. 1</p></caption></media>
<media xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="41586_2012_BFnature11252_MOESM65_ESM.ppt" id="MOESM65" orientation="portrait"><caption><p>PowerPoint slide for Fig. 2</p></caption></media>
<media xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="41586_2012_BFnature11252_MOESM66_ESM.ppt" id="MOESM66" orientation="portrait"><caption><p>PowerPoint slide for Fig. 3</p></caption></media>
<media xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="41586_2012_BFnature11252_MOESM67_ESM.ppt" id="MOESM67" orientation="portrait"><caption><p>PowerPoint slide for Fig. 4</p></caption></media>
<media xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="41586_2012_BFnature11252_MOESM68_ESM.ppt" id="MOESM68" orientation="portrait"><caption><p>PowerPoint slide for Fig. 5</p></caption></media>
</p>
          </sec>
        </app>
      </app-group>
      <fn-group>
        <fn>
          <p>(Participants are arranged by area of contribution, below, and by institution, above.)</p>
        </fn>
      </fn-group>
      <ack>
        <title>Acknowledgements</title>
        <p>This work was supported by the following grants from the National Institutes of Health: U24CA143799, U24CA143835, U24CA143840, U24CA143843, U24CA143845, U24CA143848, U24CA143858, U24CA143866, U24CA143867, U24CA143882, U24CA143883, U24CA144025, U54HG003067, U54HG003079 and U54HG003273.</p>
      </ack>
      <notes notes-type="author-contribution">
        <title>Author Contributions</title>
        <p>The Cancer Genome Atlas research network contributed collectively to this study. Biospecimens were provided by the tissue source sites and processed by the Biospecimen Core Resource. Data generation and analyses were performed by the genome-sequencing centers, cancer genome-characterization centers and genome data analysis centers. All data were released through the Data Coordinating Center. Project activities were coordinated by the National Cancer Institute and National Human Genome Research Institute project teams. Project leaders were R.K. and D.A.W. Writing team, T.A., A.J.B., T.A.C., L.D., A.H., S.R.H., R.K., P.W.L., M.M., N.S., I.S., J.M.S., J.T., V.T. and D.A.W.; mutations, M.S.L., L.R.T., D.A.W. and G.G.; copy-number and structural aberrations, A.H.R., A.J.B., A.H. and P.-C.C.; DNA methylation, T.H.; expression, J.T.A.; miRNA, G.R., A.C.; pathways, C.J.C., L.D., T.G., S.N., J.D.R., C.S., N.S., J.M.S. and V.T.</p>
      </notes>
      <notes notes-type="data-availability">
        <title>Accession codes</title>
        <sec id="d32e4671">
          <title>Data deposits</title>
          <p>dbGaP accession numbers have been provided in Supplementary Table 1.</p>
        </sec>
      </notes>
      <notes notes-type="COI-statement">
        <title>Competing interests</title>
        <p>The author declare no competing financial interests.</p>
      </notes>
      <ref-list id="Bib1">
        <title>References</title>
        <ref id="CR1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>The Cancer Genome Atlas Research Network</surname>
              </name>
            </person-group>
            <article-title>Comprehensive genomic characterization defines human glioblastoma genes and core pathways.</article-title>
            <source>Nature</source>
            <year>2008</year>
            <volume>455</volume>
            <fpage>1061</fpage>
            <lpage>1068</lpage>
            <pub-id pub-id-type="pmid">18772890</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature07385</pub-id>
            <pub-id pub-id-type="pmcid">PMC2671642</pub-id>
          </element-citation>
        </ref>
        <ref id="CR2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>The Cancer Genome Atlas Research Network</surname>
              </name>
            </person-group>
            <article-title>Integrated genomic analyses of ovarian carcinoma</article-title>
            <source>Nature</source>
            <year>2011</year>
            <volume>474</volume>
            <fpage>609</fpage>
            <lpage>615</lpage>
            <pub-id pub-id-type="pmid">21720365</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature10166</pub-id>
            <pub-id pub-id-type="pmcid">PMC3163504</pub-id>
          </element-citation>
        </ref>
        <ref id="CR3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Fearon</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>Molecular genetics of colorectal cancer</article-title>
            <source>Annu. Rev. Pathol.</source>
            <year>2011</year>
            <volume>6</volume>
            <fpage>479</fpage>
            <lpage>507</lpage>
            <pub-id pub-id-type="pmid">21090969</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev-pathol-011110-130235</pub-id>
          </element-citation>
        </ref>
        <ref id="CR4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Bass</surname>
                <given-names>AJ</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Genomic sequencing of colorectal adenocarcinomas identifies a recurrent <italic toggle="yes">VTI1A</italic>–<italic toggle="yes">TCF7L2</italic> fusion</article-title>
            <source>Nature Genet.</source>
            <year>2011</year>
            <volume>43</volume>
            <fpage>964</fpage>
            <lpage>968</lpage>
            <pub-id pub-id-type="pmid">21892161</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ng.936</pub-id>
            <pub-id pub-id-type="pmcid">PMC3802528</pub-id>
          </element-citation>
        </ref>
        <ref id="CR5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Sjoblom</surname>
                <given-names>T</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>The consensus coding sequences of human breast and colorectal cancers</article-title>
            <source>Science</source>
            <year>2006</year>
            <volume>314</volume>
            <fpage>268</fpage>
            <lpage>274</lpage>
            <pub-id pub-id-type="pmid">16959974</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1133427</pub-id>
          </element-citation>
        </ref>
        <ref id="CR6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Wood</surname>
                <given-names>LD</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>The genomic landscapes of human breast and colorectal cancers</article-title>
            <source>Science</source>
            <year>2007</year>
            <volume>318</volume>
            <fpage>1108</fpage>
            <lpage>1113</lpage>
            <pub-id pub-id-type="pmid">17932254</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1145720</pub-id>
          </element-citation>
        </ref>
        <ref id="CR7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Umar</surname>
                <given-names>A</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability</article-title>
            <source>J. Natl Cancer Inst.</source>
            <year>2004</year>
            <volume>96</volume>
            <fpage>261</fpage>
            <lpage>268</lpage>
            <pub-id pub-id-type="pmid">14970275</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jnci/djh034</pub-id>
            <pub-id pub-id-type="pmcid">PMC2933058</pub-id>
          </element-citation>
        </ref>
        <ref id="CR8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Aaltonen</surname>
                <given-names>LA</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Clues to the pathogenesis of familial colorectal cancer</article-title>
            <source>Science</source>
            <year>1993</year>
            <volume>260</volume>
            <fpage>812</fpage>
            <lpage>816</lpage>
            <pub-id pub-id-type="pmid">8484121</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.8484121</pub-id>
          </element-citation>
        </ref>
        <ref id="CR9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Ionov</surname>
                <given-names>Y</given-names>
              </name>
              <name name-style="western">
                <surname>Peinado</surname>
                <given-names>MA</given-names>
              </name>
              <name name-style="western">
                <surname>Malkhosyan</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Shibata</surname>
                <given-names>D</given-names>
              </name>
              <name name-style="western">
                <surname>Perucho</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis</article-title>
            <source>Nature</source>
            <year>1993</year>
            <volume>363</volume>
            <fpage>558</fpage>
            <lpage>561</lpage>
            <pub-id pub-id-type="pmid">8505985</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/363558a0</pub-id>
          </element-citation>
        </ref>
        <ref id="CR10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Parsons</surname>
                <given-names>R</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Hypermutability and mismatch repair deficiency in RER<sup>+</sup> tumor cells</article-title>
            <source>Cell</source>
            <year>1993</year>
            <volume>75</volume>
            <fpage>1227</fpage>
            <lpage>1236</lpage>
            <pub-id pub-id-type="pmid">8261516</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0092-8674(93)90331-j</pub-id>
          </element-citation>
        </ref>
        <ref id="CR11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Dooley</surname>
                <given-names>AL</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Nuclear factor I/B is an oncogene in small cell lung cancer</article-title>
            <source>Genes Dev.</source>
            <year>2011</year>
            <volume>25</volume>
            <fpage>1470</fpage>
            <lpage>1475</lpage>
            <pub-id pub-id-type="pmid">21764851</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1101/gad.2046711</pub-id>
            <pub-id pub-id-type="pmcid">PMC3143937</pub-id>
          </element-citation>
        </ref>
        <ref id="CR12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Major</surname>
                <given-names>MB</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Wilms tumor suppressor WTX negatively regulates WNT/β-catenin signaling</article-title>
            <source>Science</source>
            <year>2007</year>
            <volume>316</volume>
            <fpage>1043</fpage>
            <lpage>1046</lpage>
            <pub-id pub-id-type="pmid">17510365</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science/1141515</pub-id>
          </element-citation>
        </ref>
        <ref id="CR13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Mori-Akiyama</surname>
                <given-names>Y</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>SOX9 is required for the differentiation of paneth cells in the intestinal epithelium</article-title>
            <source>Gastroenterology</source>
            <year>2007</year>
            <volume>133</volume>
            <fpage>539</fpage>
            <lpage>546</lpage>
            <pub-id pub-id-type="pmid">17681175</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2007.05.020</pub-id>
          </element-citation>
        </ref>
        <ref id="CR14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Bastide</surname>
                <given-names>P</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium</article-title>
            <source>J. Cell Biol.</source>
            <year>2007</year>
            <volume>178</volume>
            <fpage>635</fpage>
            <lpage>648</lpage>
            <pub-id pub-id-type="pmid">17698607</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1083/jcb.200704152</pub-id>
            <pub-id pub-id-type="pmcid">PMC2064470</pub-id>
          </element-citation>
        </ref>
        <ref id="CR15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Jones</surname>
                <given-names>S</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Somatic mutations in the chromatin remodeling gene <italic toggle="yes">ARID1A</italic> occur in several tumor types</article-title>
            <source>Hum. Mutat.</source>
            <year>2012</year>
            <volume>33</volume>
            <fpage>100</fpage>
            <lpage>103</lpage>
            <pub-id pub-id-type="pmid">22009941</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/humu.21633</pub-id>
            <pub-id pub-id-type="pmcid">PMC3240719</pub-id>
          </element-citation>
        </ref>
        <ref id="CR16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Wilson</surname>
                <given-names>BG</given-names>
              </name>
              <name name-style="western">
                <surname>Roberts</surname>
                <given-names>CW</given-names>
              </name>
            </person-group>
            <article-title><italic toggle="yes">SWI</italic>/<italic toggle="yes">SNF</italic> nucleosome remodellers and cancer</article-title>
            <source>Nat. Rev. Cancer</source>
            <year>2011</year>
            <volume>11</volume>
            <fpage>481</fpage>
            <lpage>492</lpage>
            <pub-id pub-id-type="pmid">21654818</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrc3068</pub-id>
          </element-citation>
        </ref>
        <ref id="CR17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Minsky</surname>
                <given-names>BD</given-names>
              </name>
            </person-group>
            <article-title>Unique considerations in the patient with rectal cancer</article-title>
            <source>Semin. Oncol.</source>
            <year>2011</year>
            <volume>38</volume>
            <fpage>542</fpage>
            <lpage>551</lpage>
            <pub-id pub-id-type="pmid">21810513</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.seminoncol.2011.05.008</pub-id>
          </element-citation>
        </ref>
        <ref id="CR18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Hinoue</surname>
                <given-names>T</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Genome-scale analysis of aberrant DNA methylation in colorectal cancer</article-title>
            <source>Genome Res.</source>
            <year>2012</year>
            <volume>22</volume>
            <fpage>271</fpage>
            <lpage>282</lpage>
            <pub-id pub-id-type="pmid">21659424</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1101/gr.117523.110</pub-id>
            <pub-id pub-id-type="pmcid">PMC3266034</pub-id>
          </element-citation>
        </ref>
        <ref id="CR19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Beroukhim</surname>
                <given-names>R</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma</article-title>
            <source>Proc. Natl Acad. Sci. USA</source>
            <year>2007</year>
            <volume>104</volume>
            <fpage>20007</fpage>
            <lpage>20012</lpage>
            <pub-id pub-id-type="pmid">18077431</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0710052104</pub-id>
            <pub-id pub-id-type="pmcid">PMC2148413</pub-id>
          </element-citation>
        </ref>
        <ref id="CR20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Camps</surname>
                <given-names>J</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer</article-title>
            <source>Genes Chromosom. Cancer</source>
            <year>2009</year>
            <volume>48</volume>
            <fpage>1002</fpage>
            <lpage>1017</lpage>
            <pub-id pub-id-type="pmid">19691111</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/gcc.20699</pub-id>
            <pub-id pub-id-type="pmcid">PMC4721599</pub-id>
          </element-citation>
        </ref>
        <ref id="CR21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Varley</surname>
                <given-names>JM</given-names>
              </name>
              <name name-style="western">
                <surname>Swallow</surname>
                <given-names>JE</given-names>
              </name>
              <name name-style="western">
                <surname>Brammar</surname>
                <given-names>WJ</given-names>
              </name>
              <name name-style="western">
                <surname>Whittaker</surname>
                <given-names>JL</given-names>
              </name>
              <name name-style="western">
                <surname>Walker</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Alterations to either <italic toggle="yes">c-erb</italic>B-2(neu) or <italic toggle="yes">c-myc</italic> proto-oncogenes in breast carcinomas correlate with poor short-term prognosis</article-title>
            <source>Oncogene</source>
            <year>1987</year>
            <volume>1</volume>
            <fpage>423</fpage>
            <lpage>430</lpage>
            <pub-id pub-id-type="pmid">3330785</pub-id>
          </element-citation>
        </ref>
        <ref id="CR22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Yokota</surname>
                <given-names>J</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Amplification of <italic toggle="yes">c-erb</italic>B-2 oncogene in human adenocarcinomas <italic toggle="yes">in vivo</italic></article-title>
            <source>Lancet</source>
            <year>1986</year>
            <volume>327</volume>
            <fpage>765</fpage>
            <lpage>767</lpage>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0140-6736(86)91782-4</pub-id>
            <pub-id pub-id-type="pmid">2870269</pub-id>
          </element-citation>
        </ref>
        <ref id="CR23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>van der Flier</surname>
                <given-names>LG</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Transcription factor achaete scute-like 2 controls intestinal stem cell fate</article-title>
            <source>Cell</source>
            <year>2009</year>
            <volume>136</volume>
            <fpage>903</fpage>
            <lpage>912</lpage>
            <pub-id pub-id-type="pmid">19269367</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2009.01.031</pub-id>
          </element-citation>
        </ref>
        <ref id="CR24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Jubb</surname>
                <given-names>AM</given-names>
              </name>
              <name name-style="western">
                <surname>Hoeflich</surname>
                <given-names>KP</given-names>
              </name>
              <name name-style="western">
                <surname>Haverty</surname>
                <given-names>PM</given-names>
              </name>
              <name name-style="western">
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Koeppen</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Ascl2 and 11p15.5 amplification in colorectal cancer</article-title>
            <source>Gut</source>
            <year>2011</year>
            <volume>60</volume>
            <fpage>1606</fpage>
            <lpage>1607</lpage>
            <pub-id pub-id-type="pmid">21106550</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gut.2010.231746</pub-id>
          </element-citation>
        </ref>
        <ref id="CR25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Stange</surname>
                <given-names>DE</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Expression of an <italic toggle="yes">ASCL2</italic> related stem cell signature and <italic toggle="yes">IGF2</italic> in colorectal cancer liver metastases with 11p15.5 gain</article-title>
            <source>Gut</source>
            <year>2010</year>
            <volume>59</volume>
            <fpage>1236</fpage>
            <lpage>1244</lpage>
            <pub-id pub-id-type="pmid">20479215</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gut.2009.195701</pub-id>
          </element-citation>
        </ref>
        <ref id="CR26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Cui</surname>
                <given-names>H</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Loss of <italic toggle="yes">IGF2</italic> imprinting: a potential marker of colorectal cancer risk</article-title>
            <source>Science</source>
            <year>2003</year>
            <volume>299</volume>
            <fpage>1753</fpage>
            <lpage>1755</lpage>
            <pub-id pub-id-type="pmid">12637750</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1080902</pub-id>
          </element-citation>
        </ref>
        <ref id="CR27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Nakagawa</surname>
                <given-names>H</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of <italic toggle="yes">H19</italic>-associated CTCF-binding sites in colorectal cancer</article-title>
            <source>Proc. Natl Acad. Sci. USA</source>
            <year>2001</year>
            <volume>98</volume>
            <fpage>591</fpage>
            <lpage>596</lpage>
            <pub-id pub-id-type="pmid">11120891</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.011528698</pub-id>
            <pub-id pub-id-type="pmcid">PMC14632</pub-id>
          </element-citation>
        </ref>
        <ref id="CR28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Veronese</surname>
                <given-names>A</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Oncogenic role of <italic toggle="yes">miR-483-3p</italic> at the <italic toggle="yes">IGF2/483</italic> locus</article-title>
            <source>Cancer Res.</source>
            <year>2010</year>
            <volume>70</volume>
            <fpage>3140</fpage>
            <lpage>3149</lpage>
            <pub-id pub-id-type="pmid">20388800</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/0008-5472.CAN-09-4456</pub-id>
            <pub-id pub-id-type="pmcid">PMC4303586</pub-id>
          </element-citation>
        </ref>
        <ref id="CR29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Ciriello</surname>
                <given-names>G</given-names>
              </name>
              <name name-style="western">
                <surname>Cerami</surname>
                <given-names>E</given-names>
              </name>
              <name name-style="western">
                <surname>Sander</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Schultz</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Mutual exclusivity analysis identifies oncogenic network modules</article-title>
            <source>Genome Res.</source>
            <year>2012</year>
            <volume>22</volume>
            <fpage>398</fpage>
            <lpage>406</lpage>
            <pub-id pub-id-type="pmid">21908773</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1101/gr.125567.111</pub-id>
            <pub-id pub-id-type="pmcid">PMC3266046</pub-id>
          </element-citation>
        </ref>
        <ref id="CR30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Brady</surname>
                <given-names>CA</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression</article-title>
            <source>Cell</source>
            <year>2011</year>
            <volume>145</volume>
            <fpage>571</fpage>
            <lpage>583</lpage>
            <pub-id pub-id-type="pmid">21565614</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2011.03.035</pub-id>
            <pub-id pub-id-type="pmcid">PMC3259909</pub-id>
          </element-citation>
        </ref>
        <ref id="CR31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Rivera</surname>
                <given-names>MN</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>An X chromosome gene, <italic toggle="yes">WTX</italic>, is commonly inactivated in Wilms tumor</article-title>
            <source>Science</source>
            <year>2007</year>
            <volume>315</volume>
            <fpage>642</fpage>
            <lpage>645</lpage>
            <pub-id pub-id-type="pmid">17204608</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1137509</pub-id>
          </element-citation>
        </ref>
        <ref id="CR32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Scheel</surname>
                <given-names>SK</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Mutations in the W<italic toggle="yes">TX</italic>-gene are found in some high-grade microsatellite instable (MSI-H) colorectal cancers</article-title>
            <source>BMC Cancer</source>
            <year>2010</year>
            <volume>10</volume>
            <fpage>413</fpage>
            <pub-id pub-id-type="pmid">20696052</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1471-2407-10-413</pub-id>
            <pub-id pub-id-type="pmcid">PMC2928794</pub-id>
          </element-citation>
        </ref>
        <ref id="CR33">
          <label>33</label>
          <mixed-citation publication-type="other">Forbes, S. A. et al. The catalogue of somatic mutations in cancer (COSMIC). <italic toggle="yes">Curr. Protoc. Hum. Genet.</italic> Ch. 10, Unit 10.11. (2008)<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/0471142905.hg1011s57</pub-id><pub-id pub-id-type="pmcid">PMC2705836</pub-id><pub-id pub-id-type="pmid">18428421</pub-id></mixed-citation>
        </ref>
        <ref id="CR34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Massagué</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Blain</surname>
                <given-names>SW</given-names>
              </name>
              <name name-style="western">
                <surname>Lo</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>TGFβ signaling in growth control, cancer, and heritable disorders</article-title>
            <source>Cell</source>
            <year>2000</year>
            <volume>103</volume>
            <fpage>295</fpage>
            <lpage>309</lpage>
            <pub-id pub-id-type="pmid">11057902</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0092-8674(00)00121-5</pub-id>
          </element-citation>
        </ref>
        <ref id="CR35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Vaske</surname>
                <given-names>CJ</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM</article-title>
            <source>Bioinformatics</source>
            <year>2010</year>
            <volume>26</volume>
            <fpage>i237</fpage>
            <lpage>i245</lpage>
            <pub-id pub-id-type="pmid">20529912</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bioinformatics/btq182</pub-id>
            <pub-id pub-id-type="pmcid">PMC2881367</pub-id>
          </element-citation>
        </ref>
        <ref id="CR36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>House</surname>
                <given-names>CD</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Voltage-gated Na<sup>+</sup> channel <italic toggle="yes">SCN5A</italic> is a key regulator of a gene transcriptional network that controls colon cancer invasion</article-title>
            <source>Cancer Res.</source>
            <year>2010</year>
            <volume>70</volume>
            <fpage>6957</fpage>
            <lpage>6967</lpage>
            <pub-id pub-id-type="pmid">20651255</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/0008-5472.CAN-10-1169</pub-id>
            <pub-id pub-id-type="pmcid">PMC2936697</pub-id>
          </element-citation>
        </ref>
        <ref id="CR37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Liu</surname>
                <given-names>Z</given-names>
              </name>
              <name name-style="western">
                <surname>Lu</surname>
                <given-names>H</given-names>
              </name>
              <name name-style="western">
                <surname>Jiang</surname>
                <given-names>Z</given-names>
              </name>
              <name name-style="western">
                <surname>Pastuszyn</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Hu</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Apolipoprotein l6, a novel proapoptotic Bcl-2 homology 3-only protein, induces mitochondria-mediated apoptosis in cancer cells</article-title>
            <source>Mol. Cancer Res.</source>
            <year>2005</year>
            <volume>3</volume>
            <fpage>21</fpage>
            <lpage>31</lpage>
            <pub-id pub-id-type="pmid">15671246</pub-id>
          </element-citation>
        </ref>
        <ref id="CR38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Topol</surname>
                <given-names>L</given-names>
              </name>
              <name name-style="western">
                <surname>Chen</surname>
                <given-names>W</given-names>
              </name>
              <name name-style="western">
                <surname>Song</surname>
                <given-names>H</given-names>
              </name>
              <name name-style="western">
                <surname>Day</surname>
                <given-names>TF</given-names>
              </name>
              <name name-style="western">
                <surname>Yang</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Sox9 inhibits Wnt signaling by promoting β-catenin phosphorylation in the nucleus</article-title>
            <source>J. Biol. Chem.</source>
            <year>2009</year>
            <volume>284</volume>
            <fpage>3323</fpage>
            <lpage>3333</lpage>
            <pub-id pub-id-type="pmid">19047045</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M808048200</pub-id>
            <pub-id pub-id-type="pmcid">PMC2631972</pub-id>
          </element-citation>
        </ref>
        <ref id="CR39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Nagl</surname>
                <given-names>NG</given-names>
                <suffix>Jr</suffix>
              </name>
              <name name-style="western">
                <surname>Zweitzig</surname>
                <given-names>DR</given-names>
              </name>
              <name name-style="western">
                <surname>Thimmapaya</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Beck</surname>
                <given-names>GR</given-names>
                <suffix>Jr</suffix>
              </name>
              <name name-style="western">
                <surname>Moran</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>The <italic toggle="yes">c-myc</italic> gene is a direct target of mammalian SWI/SNF-related complexes during differentiation-associated cell cycle arrest</article-title>
            <source>Cancer Res.</source>
            <year>2006</year>
            <volume>66</volume>
            <fpage>1289</fpage>
            <lpage>1293</lpage>
            <pub-id pub-id-type="pmid">16452181</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/0008-5472.CAN-05-3427</pub-id>
          </element-citation>
        </ref>
        <ref id="CR40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Chen</surname>
                <given-names>B</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer</article-title>
            <source>Nat. Chem. Biol.</source>
            <year>2009</year>
            <volume>5</volume>
            <fpage>100</fpage>
            <lpage>107</lpage>
            <pub-id pub-id-type="pmid">19125156</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nchembio.137</pub-id>
            <pub-id pub-id-type="pmcid">PMC2628455</pub-id>
          </element-citation>
        </ref>
        <ref id="CR41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Ewan</surname>
                <given-names>K</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>A useful approach to identify novel small-molecule inhibitors of Wnt-dependent transcription</article-title>
            <source>Cancer Res.</source>
            <year>2010</year>
            <volume>70</volume>
            <fpage>5963</fpage>
            <lpage>5973</lpage>
            <pub-id pub-id-type="pmid">20610623</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/0008-5472.CAN-10-1028</pub-id>
            <pub-id pub-id-type="pmcid">PMC2912498</pub-id>
          </element-citation>
        </ref>
        <ref id="CR42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Sack</surname>
                <given-names>U</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells</article-title>
            <source>Mol. Biol. Cell</source>
            <year>2011</year>
            <volume>22</volume>
            <fpage>3344</fpage>
            <lpage>3354</lpage>
            <pub-id pub-id-type="pmid">21795396</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1091/mbc.E10-09-0739</pub-id>
            <pub-id pub-id-type="pmcid">PMC3172260</pub-id>
          </element-citation>
        </ref>
        <ref id="CR43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Chen</surname>
                <given-names>K</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>BreakDancer: an algorithm for high-resolution mapping of genomic structural variation</article-title>
            <source>Nature Methods</source>
            <year>2009</year>
            <volume>6</volume>
            <fpage>677</fpage>
            <lpage>681</lpage>
            <pub-id pub-id-type="pmid">19668202</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nmeth.1363</pub-id>
            <pub-id pub-id-type="pmcid">PMC3661775</pub-id>
          </element-citation>
        </ref>
        <ref id="CR44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Xi</surname>
                <given-names>R</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion</article-title>
            <source>Proc. Natl Acad. Sci. USA</source>
            <year>2011</year>
            <volume>108</volume>
            <fpage>E1128</fpage>
            <lpage>E1136</lpage>
            <pub-id pub-id-type="pmid">22065754</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1110574108</pub-id>
            <pub-id pub-id-type="pmcid">PMC3219132</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </article>
</pmc-articleset>
